[go: up one dir, main page]

WO2016133324A1 - Method for diagnosing inflammatory respiratory diseases using outer membrane vesicles derived from bacteria - Google Patents

Method for diagnosing inflammatory respiratory diseases using outer membrane vesicles derived from bacteria Download PDF

Info

Publication number
WO2016133324A1
WO2016133324A1 PCT/KR2016/001502 KR2016001502W WO2016133324A1 WO 2016133324 A1 WO2016133324 A1 WO 2016133324A1 KR 2016001502 W KR2016001502 W KR 2016001502W WO 2016133324 A1 WO2016133324 A1 WO 2016133324A1
Authority
WO
WIPO (PCT)
Prior art keywords
bacteria
extracellular vesicles
derived
lung cancer
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2016/001502
Other languages
French (fr)
Korean (ko)
Inventor
김윤근
김유선
지영구
오연목
조유숙
최준표
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asan Foundation
Ewha Womans University
Industry Academic Cooperation Foundation of Dankook University
Original Assignee
Asan Foundation
Ewha Womans University
Industry Academic Cooperation Foundation of Dankook University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asan Foundation, Ewha Womans University, Industry Academic Cooperation Foundation of Dankook University filed Critical Asan Foundation
Publication of WO2016133324A1 publication Critical patent/WO2016133324A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Definitions

  • the present invention relates to a method for diagnosing respiratory inflammatory disease using bacterial-derived extracellular vesicles, and more specifically to measuring asthma and chronic obstruction by measuring specific antibodies against bacterial-derived extracellular vesicles or proteins derived from these vesicles in indoor dust. Lung diseases, and methods for diagnosing lung cancer.
  • Indoor dust includes Bacillus sp . , Staphylococcus aureus , Staphylococcus epidermidis , and Pseudomonas.
  • Substances derived from these bacteria, such as lipopolysaccharide (LPS) or peptidoglycan are known to induce the production of inflammatory cytokines in immune cells and lung epidermal cells.
  • LPS lipopolysaccharide
  • peptidoglycan are known to induce the production of inflammatory cytokines in immune cells and lung epidermal cells.
  • Gram-negative bacteria constantly secrete extracellular vesicles (also called outer membrane vesicles). Nanometer-sized extracellular vesicles secreted by bacteria are substances that are secreted to exchange information between cells, which are ultrafine dust. Extracellular vesicles secreted by Gram-negative bacteria are spherical phospholipid bilayers, 20-200 nm in size. The extracellular vesicles have outer membrane proteins that can control the inflammatory response of the host as well as LPS. In addition, gram-positive bacteria have been reported to secrete extracellular vesicles to the outside, and proteome analysis has reported that endoplasmic reticulum contains proteins that induce inflammation. Therefore, inhalation of extracellular vesicles in indoor dust can cause inflammatory reactions in alveolar macrophages as well as airway epithelial cells.
  • respiratory inflammatory diseases can be largely classified into rhinitis and sinusitis occurring in the upper airway, asthma and bronchitis in the lower respiratory tract, bronchiolitis and emphysema in the small airways.
  • asthma is characterized by reversible airway obstruction, there are 350 million people worldwide, about 2.3 million patients in Korea.
  • Chronic obstructive pulmonary disease COPD
  • Chronic obstructive bronchitis, chronic obstructive bronchiolitis, emphysema and the like are the causes of chronic obstructive pulmonary disease.
  • protein antigens allergens
  • stimulating factors such as smoking are known to be important in the cause of chronic obstructive pulmonary disease.
  • the present invention by identifying the bacteria that can act as a causative agent of asthma, chronic obstructive pulmonary disease, lung cancer in bacteria-derived extracellular vesicles isolated from the indoor dust through a metagenome analysis was completed.
  • an object of the present invention is to provide a method for diagnosing asthma, chronic obstructive pulmonary disease, and lung cancer using bacterial extracellular vesicles or proteins derived from the endoplasmic reticulum contained in indoor dust.
  • the present invention provides a method for diagnosing a respiratory inflammatory disease, comprising the following steps.
  • the extracellular vesicles, and proteins Staphylococci (Staphylococcus), Acinetobacter (Acinetobacter), Pseudomonas (Pseudomonas) and Enterobacter (Enterobacter) derived from one or more bacteria selected from the group consisting of It may be.
  • the Staphylococcus aureus is Staphylococcus aureus
  • the Acinetobacter is Acinetobacter baumannii
  • the Pseudomonas aeruginosa is Pseudomonas aeruginosa , May be Enterobacter aerogenes .
  • the patient sample may be selected from the group consisting of blood and sputum.
  • the IgG antibody may be IgG1 or IgG4.
  • the extracellular vesicles are characterized in that the average diameter of 10-300 nm.
  • the respiratory inflammatory disease may be selected from the group consisting of asthma, chronic obstructive pulmonary disease, and lung cancer.
  • the present invention provides a diagnostic use of respiratory inflammatory diseases of indoor dust bacteria-derived extracellular vesicles.
  • Staphylococcus aureus present in a large quantity in dust in the room air (Staphylococcus), Acinetobacter (Acinetobacter), Pseudomonas (Pseudomonas), and Enterobacter (Enterobacter) in germ cells derived from outside the ER because it can lead to respiratory inflammatory diseases
  • the present invention It can be usefully used as a method for diagnosing asthma, chronic obstructive pulmonary disease and lung cancer by measuring the antibody-specific extracellular vesicles or specific antibodies to the vesicle-derived proteins in a patient sample.
  • 5 is a result of analyzing the distribution of bacteria and extracellular vesicles separated from the indoor dust seasonally at the genus level through a metagenomic analysis.
  • FIG. 6 shows the distribution and the positive rate of extracellular vesicle-specific IgG antibodies in indoor dust measured from blood and sputum samples of control, asthma, chronic obstructive pulmonary disease (COPD), lung cancer patients (Lung cancer). Is the result.
  • COPD chronic obstructive pulmonary disease
  • Figure 7 shows the number of sensitized to each bacteria-derived extracellular vesicles in the control group (Asthma), chronic obstructive pulmonary disease (COPD), lung cancer patients (positive) showed positive extracellular vesicle-specific IgG antibody This figure shows the distribution of.
  • FIG. 8 shows the number of sensitized bacteria-derived extracellular vesicles in normal, control, asthma, chronic obstructive pulmonary disease (COPD), and lung cancer patients with positive extracellular vesicle-specific IgG1 antibodies.
  • Figure shows the distribution.
  • FIG. 9 shows the number of sensitized bacteria-derived extracellular vesicles in normal, control, asthma, chronic obstructive pulmonary disease (COPD), and lung cancer patients with positive extracellular vesicle-specific IgG4 antibodies.
  • Figure shows the distribution.
  • the present invention relates to a method for diagnosing asthma, chronic obstructive pulmonary disease, and lung cancer using a bacterial-derived extracellular vesicle or a protein derived from the endoplasmic reticulum present in indoor dust causing respiratory inflammatory disease.
  • the characteristics of bacteria-derived extracellular vesicles present in indoor dust causing inflammatory respiratory diseases were evaluated and the causative factors (bacteria) of extracellular vesicles were identified.
  • the DNA of the extracellular vesicles separated from the indoor dust was separated and then subjected to metagenomic analysis to analyze the distribution of bacteria and bacteria-derived extracellular vesicles.
  • samples from three patients and normal groups suffering from the disease to evaluate the sensitization of bacteria-derived extracellular vesicles present in indoor dust and its association with asthma, chronic obstructive pulmonary disease, and lung cancer
  • the amount of extracellular vesicle-specific IgG antibody was obtained.
  • Correlation analysis revealed that 4.4% of normal subjects, 13.6% of asthmatic patients, 29.3% of patients with chronic obstructive pulmonary disease, and 54.9% of lung cancer patients were sensitized to extracellular vesicles (see Example 4). .
  • the above-described one staphylococci Staphylococcus
  • Acinetobacter Acinetobacter
  • Pseudomonas Pseudomonas
  • Acinetobacter extracellular vesicles were isolated from baumannii
  • Pseudomonas aeruginosa and Enterobacter aerogenes
  • the extracellular vesicle specific IgG, IgG1, IgG4 antibodies of each group were measured.
  • the risk of asthma, chronic obstructive pulmonary disease, and lung cancer increased by 4.5 and 17.5 times, and Enterobacter When sensitized to aerogenes- derived extracellular vesicles, the risk of asthma, chronic obstructive pulmonary disease, and lung cancer was increased by 2.4, 2.8, and 8.3 times (see Example 6).
  • the association between the number of sensitization and asthma, chronic obstructive pulmonary disease, lung cancer in the four bacteria-derived extracellular vesicles was measured for at least three bacterial-derived vesicles in asthma, chronic obstructive pulmonary disease, and lung cancer patients.
  • IgG1 all four bacterial-derived vesicles were found in chronic obstructive pulmonary disease and lung cancer patients only. Increased. In the case of IgG4, it was confirmed that two or three bacteria-derived vesicles increased in lung cancer patients (see Example 7).
  • 'metagenome' used in the present invention also referred to as 'gunoelectric', refers to the sum total of the genome including all viruses, bacteria, fungi, etc. in an isolated area such as soil and animal intestine. It is used as a concept of genome explaining the identification of many microorganisms at once using sequencer to analyze microorganisms that are not.
  • the metagenome does not refer to one genome or genome, but to a kind of mixed dielectric as the genome of all species of one environmental unit. This is a term from the point of view of defining a species in the course of the evolution of biology in terms of functional species as well as various species that interact with each other to create a complete species.
  • rapid sequencing is used to analyze all DNA and RNA, regardless of species, to identify all species in one environment, and to identify interactions and metabolism.
  • the present invention comprises the steps of reacting a patient sample with extracellular vesicles or proteins derived from the indoor dust bacteria; Reacting the reaction with an anti-human IgG antibody to determine the amount of IgG antibody in the sample; And it provides a method for diagnosing respiratory inflammatory disease comprising the step of determining the respiratory inflammatory disease when the amount of IgG antibody in the sample is increased more than two times compared to the normal person.
  • extracellular vesicles refers to nanoscale nanovesicles secreted by various bacteria.
  • the extracellular vesicles present in the indoor dust are caused by bacteria living in the room, house dust mites, wheels, pets, humans, etc., or by various kinds of bacteria living in and around structures including structures.
  • the extracellular vesicles may be produced, but the average diameter may be 10-300 nm, but is not limited thereto.
  • a protein contained in the extracellular vesicles may be used as an antigen instead of the extracellular vesicles, but is not limited thereto.
  • Staphylococcus aureus Staphylococcus
  • Acinetobacter Acinetobacter
  • Pseudomonas Pseudomonas
  • Enterobacter Enterobacter
  • staphylococcus aureus is Staphylococcus aureus
  • the acinetobacter is Acinetobacter Baumani ( Acinetobacter) baumannii
  • the pseudomonas is Pseudomonas aeruginosa
  • the enterobacter may be Enterobacter aerogenes , but is not limited thereto.
  • the patient sample of the present invention may be selected from the group consisting of blood and sputum, but is not limited thereto.
  • the antibody of the present invention may be IgG, IgA, or IgE, IgG antibody may be IgG1 or IgG4, but is not limited thereto.
  • the respiratory inflammatory disease of the present invention may be selected from the group consisting of asthma, chronic obstructive pulmonary disease, and lung cancer, but is not limited thereto.
  • the dust present in the filter of the vacuum cleaner was transferred to a clean glass bottle to measure the mass. 5 g of indoor dust was placed in a beaker containing 200 ml of PBS (phosphate-buffered saline) and dissolved at 4 ° C. for 12 hours. Afterwards, the large amount of foreign matter is first filtered out, the filtered solution is divided into high speed centrifuge tubes, and high speed centrifugation is performed at 10,000 xg for 15 minutes at 4 ° C. Performed twice in succession.
  • PBS phosphate-buffered saline
  • the filtered supernatant was divided into a 70 mL ultracentrifuge tube, and then stored at 4 ° C., 100,000 xg. The ultracentrifugation (ultracetrifugation) was performed for 4 hours at. The supernatant was discarded and the extracellular vesicles were extracted by dissolving the precipitate under the tube with PBS.
  • the dust separated from the two mattress bed mattress in spring, summer, autumn and winter contains 115.6, 83.8, 71.3, 96.1 ⁇ g (protein / g dust) extracellular vesicles, respectively It was confirmed.
  • the extracellular vesicles were observed by transmission electron microscopy (TEM) to evaluate the properties of the extracellular vesicles separated by the method of Example 1.
  • TEM transmission electron microscopy
  • 10 ⁇ l was placed on 400-mesh copper grids.
  • staining with 2% uranyl acetate (uranyl acetate) and blowing water was observed under 100 kV using a JEM1011 microscope (JEOL, Peabody, MA, USA).
  • the size of the extracellular vesicles separated from the bed mattress dust was measured by dynamic light scattering. After diluting the extracellular endoplasmic reticulum to 10 ⁇ g / ml concentration, 1 mL into the cuvette (cuvette) and measured the degree of light scattering at 633 nm wavelength using Zetasizer Nano S (Malvern Instrument Ltd. Worcestershire, UK) (30 X 10 times / sample).
  • the size of the extracellular vesicles separated from the bed mattress dust in spring, summer, autumn and winter was 30-220, 20-100, 30-220 and 50-250 nm, respectively.
  • DNA was extracted from bacteria and extracellular vesicles present in the indoor dust and subjected to metagenomic analysis to analyze the distribution of bacteria and bacteria-derived extracellular vesicles at the phylum level and genus level.
  • DNA was extracted from the bacterial and extracellular vesicles present in the indoor dust using a DNA extraction kit (Bioneer Inc., Daejeon, Korea), and the DNA library was prepared according to the GS FLX titanium library prep guide. Subsequently, the production library was quantified using Picogreen assay (Invitrogen, Carlsbad, CA, USA), and emulsion PCR (emulsion PCR; emPCR) using GSFLX titanium emPCR Kit (454 Life Sciences, Basel, Switzerland) for amplification of the production library. It was performed by.
  • Picogreen assay Invitrogen, Carlsbad, CA, USA
  • emulsion PCR emulsion PCR; emPCR
  • the production library was fixed on the beads, mixed with an amplification mix and oil, mixed vigorously in Tissue Lyser II (Qiagen, Limburg, Netherlands) to form “micro-reactors”, and the fluid was dispensed on 96-well plates. PCR amplification reactions were performed.
  • DNA sequencing of the isolated DNA the DNA isolated by the above method was amplified by a polymerase chain reaction, and then the bead containing the amplified library was separated through the filter by breaking the emulsion state. Then, only beads having amplified libraries were purified using biotinylated primer A (complementary to adapter A), which can be attached to streptavidin-coated magnetic beads (streptavidin-coated magnetic beads).
  • the distribution of bacteria and bacteria-derived extracellular vesicles present in the dust was analyzed at the genus level.
  • a Le Clerc cyano (Leclercia) in bacteria is achieved when the main yirueotgo, Gram-positive bacteria in the main all four seasons, Staphylococcus (Staphylococcus) in bacteria belonging to the Firmicutes door in all seasons.
  • samples were prepared from blood and sputum in four groups.
  • the first group consisted of 294 Asthma patients who had undergone a medical diagnosis based on reversible airway obstruction.
  • the second group had a 1-second expiratory volume / total lung capacity (FEV1 / FVC) after bronchodilator use regardless of smoking history.
  • the study consisted of 242 patients with chronic obstructive pulmonary disease (COPD).
  • COPD chronic obstructive pulmonary disease
  • the third group consisted of patients diagnosed with lung cancer at Dankook University Hospital from November 2003 to March 2011.
  • the fourth group was the control group. It consists of 90 members of the public.
  • the four groups are shown in detail in Table 1 below.
  • vesicle-specific IgG antibodies were measured in samples obtained from the patients and controls.
  • 50 ng of extracellular vesicles were placed in each well of a 96-well plate for one day.
  • anti-human IgG antibodies were placed in place of extracellular vesicles.
  • 5% skim milk powder filled the antibody and extracellular vesicle seating gap, and the obtained sample was reacted by diluting 1000-fold in 5% skim milk powder.
  • horseradish peroxidase conjugated secondary antibody (Horseradish peroxidase-conjugated anti-IgG) (abcam, Cambridge, UK) was diluted in 5% skim milk solution, and then reacted with an IgG antibody through a microplate reader. The amount was measured. Sensitization to extracellular vesicles in dust was defined as positive when more than 95% of vesicle-specific IgG antibody values present in normal samples.
  • Example 6 Chronic Obstructive Pulmonary Disease In lung cancer patient samples Staphylococcus , Acinetobacter , Pseudomonas , Enterobacter Bacterial origin Extracellular Endoplasmic reticulum IgG , IgG1, IgG4 Antibody measurement
  • Each bacterium originated Extracellular Endoplasmic reticulum separation and Extracellular Endoplasmic reticulum IgG , IgG1 , IgG4 antibody measurement
  • Example 3 within the Staphylococcus aureus of the meta-house dust in genome analysis (Staphylococcus), and based on the findings that the Acinetobacter (Acinetobacter), Pseudomonas (Pseudomonas), Enterobacter (Enterobacter) in germ cells derived from outside the endoplasmic reticulum are large amounts present Specific IgG, IgG1, IgG4 antibodies against extracellular vesicles derived from the bacteria were measured in the four groups described in Example 4, namely, asthma, chronic obstructive pulmonary disease, lung cancer, and blood and sputum of normal persons. .
  • Bacteria corresponding to each genus, Staphylococcus aureus , Acinetobacter baumannii ), Pseudomonas aeruginosa ), and enterobacter aerogenes were inoculated in a liquid nutrient medium and incubated at 37 ° C. under agitation / constant incubator until the absorbance was 1.5. Thereafter, centrifugation was performed at 4 ° C. at 10,000 ⁇ g for 20 minutes using a high-speed centrifuge to separate bacteria and supernatant, and only the supernatant was removed and passed once through a 0.45 ⁇ m membrane filter.
  • the supernatant was concentrated to 300 ml with a quickstand (GE healthcare) for concentration for high-speed centrifugation, and then passed once through a membrane filter (0.22 ⁇ m). This was divided into ultra high-speed centrifuge tubes (45 Ti, 70 ml, Beckman coulter), and ultra-high centrifugation was performed at 4 ° C. and 100,000 x g for 3 hours. Outer endoplasmic reticulum was isolated.
  • each secondary antibody (Horseradish peroxidase-conjugated anti-IgG, anti-IgG1, anti-IgG4) (abcam, Cambridge, UK) conjugated with horseradish peroxidase was diluted and reacted with 5% skim milk powder. Then, the amount of each IgG antibody was measured through a microplate reader. Sensitization to each bacterial-derived extracellular vesicles was defined as positive when showing at least 95% of the vesicle-specific IgG, IgG1, IgG4 antibody values present in normal human blood and sputum.
  • Staphylococcus aureus Staphylococcus aureus Origin Extracellular Endoplasmic reticulum Sensitization asthma, Chronic Obstructive Pulmonary Disease Association of lung cancer
  • Acinetobacter Baumani Acinetobacter baumannii Origin Extracellular Endoplasmic reticulum and asthma, Chronic Obstructive Pulmonary Disease Association of lung cancer
  • Pseudomonas aeruginosa Pseudomonas aeruginosa Origin Extracellular Endoplasmic reticulum Sensitization asthma, Chronic Obstructive Pulmonary Disease Association of lung cancer
  • Enterobacter Aerogenes Enterobacter aerogenes Origin Extracellular Endoplasmic reticulum and asthma, Chronic Obstructive Pulmonary Disease Association of lung cancer
  • Example 7 Origin of the above four bacteria Extracellular On the endoplasmic reticulum Sensitization Asthma, Chronic Association between obstructive pulmonary disease and lung cancer
  • Example 6 Four bacteria of Example 6, namely Staphylococcus aureus , Acinetobacter Baumani ( Acinetobacter) baumannii ), Pseudomonas aeruginosa ), Enterobacter The purpose of this study was to determine the relationship between the number of aerogenes ) -derived extracellular vesicles and their sensitivity to disease.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to a method for diagnosing inflammatory respiratory diseases using outer membrane vesicles derived from bacteria and, more specifically, to a method for diagnosing asthma, chronic obstructive pulmonary disease, and lung cancer by measuring specific antibodies to outer membrane vesicles derived from bacteria existing in indoor dust or to proteins derived from the outer membrane vesicles. The outer membrane vesicles derived from Staphylococcus spp., Acinetobacter spp., Pseudomonas spp., and Enterobacter spp., which exist in large quantities in dust in the indoor air, may cause inflammatory respiratory diseases, and thus the present invention can be favorably used as a method for diagnosing asthma, chronic obstructive pulmonary disease, and lung cancer, by measuring specific antibodies to outer membrane vesicles/proteins derived from the bacteria in patient samples.

Description

세균 유래 세포밖 소포체를 이용한 호흡기 염증성 질환의 진단방법Diagnosis of Respiratory Inflammatory Disease Using Bacteria-derived Extracellular Vesicles

본 발명은 세균 유래 세포밖 소포체를 이용한 호흡기 염증성 질환의 진단방법에 관한 것으로서, 보다 구체적으로는 실내 먼지에 존재하는 세균 유래 세포밖 소포체 또는 이 소포체 유래 단백질에 대한 특이 항체를 측정함으로써 천식, 만성폐쇄성폐질환, 및 폐암을 진단하기 위한 방법에 관한 것이다. The present invention relates to a method for diagnosing respiratory inflammatory disease using bacterial-derived extracellular vesicles, and more specifically to measuring asthma and chronic obstruction by measuring specific antibodies against bacterial-derived extracellular vesicles or proteins derived from these vesicles in indoor dust. Lung diseases, and methods for diagnosing lung cancer.

실내에 존재하는 먼지에는 바실러스(Bacillus sp .), 스타필로코커스 아우레우스(Staphylococcus aureus), 스타필로코커스 에피더미디스(Staphylococcus epidermidis), 슈도모나스 스투체리(Pseudomonas stutzeri), 스트렙토마이세테스(Streptomycetes), 코리네박테리아세아에(Corynebacteriaceae), 대장균(Escherichia coli) 등 그람 음성균과 그람 양성균을 포함하는 여러 종류의 세균이 서식한다. 이들 세균에서 유래한 물질, 예를 들어, 내독소(lipopolysaccharide; LPS)나 펩티도글리칸(peptidoglycan) 등은 면역세포 및 폐 표피 세포에서 염증성 사이토카인의 생성을 유도한다고 알려져 있다. Indoor dust includes Bacillus sp . , Staphylococcus aureus , Staphylococcus epidermidis , and Pseudomonas. A variety of bacteria, including Gram-negative and Gram-positive bacteria, exist, including stutzeri , Streptomycete s, Corynebacteriaceae , and Escherichia coli . Substances derived from these bacteria, such as lipopolysaccharide (LPS) or peptidoglycan, are known to induce the production of inflammatory cytokines in immune cells and lung epidermal cells.

그람 음성균은 외부로 세포밖 소포체(outer membrane vesicles 이라고도 함)를 상시 분비한다. 세균이 분비하는 나노미터 크기의 세포밖 소포체는 세포 사이에 정보 교환을 위해 분비되는 물질로 초미세먼지에 해당한다. 그람 음성균에서 분비되는 세포밖 소포체는 구형의 인지질 이중층으로 되어 있으며, 그 크기는 20-200 nm이다. 상기 세포밖 소포체는 LPS 뿐만 아니라 숙주의 염증반응을 조절할 수 있는 외막 단백질(outer membrane protein)을 가지고 있다. 또한, 그람 양성균에서도 외부로 세포밖 소포체가 분비됨이 보고되었고, 프로테옴(proteome) 분석을 통해 소포체 내에는 염증을 유도하는 단백질이 포함되어 있음이 보고되었다. 따라서 실내 먼지내 세포밖 소포체를 흡입했을 때 폐포 내 대식세포뿐만 아니라 기도의 상피세포에서도 염증반응을 유발할 수 있다. Gram-negative bacteria constantly secrete extracellular vesicles (also called outer membrane vesicles). Nanometer-sized extracellular vesicles secreted by bacteria are substances that are secreted to exchange information between cells, which are ultrafine dust. Extracellular vesicles secreted by Gram-negative bacteria are spherical phospholipid bilayers, 20-200 nm in size. The extracellular vesicles have outer membrane proteins that can control the inflammatory response of the host as well as LPS. In addition, gram-positive bacteria have been reported to secrete extracellular vesicles to the outside, and proteome analysis has reported that endoplasmic reticulum contains proteins that induce inflammation. Therefore, inhalation of extracellular vesicles in indoor dust can cause inflammatory reactions in alveolar macrophages as well as airway epithelial cells.

한편, 호흡기 염증성 질환은 크게 상기도에 발생하는 비염 및 부비동염, 하기도에 발생하는 천식 및 기관지염, 소기도에 발생하는 세기관지염 및 폐기종으로 분류할 수 있다. 임상적으로 기도폐색을 초래하는 질환으로, 천식은 가역적인 기도폐색을 특징으로 하고, 전 세계 3억 5000만 명, 국내 약 230만 명의 환자가 존재한다. 만성폐쇄성폐질환(chronic obstructive pulmonary disease; COPD)은 비가역적 기도폐색을 특징으로 하는데, 만성폐쇄성기관지염, 만성폐쇄성세기관지염, 폐기종 등이 만성폐쇄성폐질환의 원인 질환이다. 염증성 호흡기질환의 원인과 관련해서, 천식인 경우 실내 공기 중에 존재하는 단백질 항원(알레르겐)이 중요하다고 알려져 있고, 만성폐쇄성폐질환의 원인과 관련해서 흡연과 같은 자극성 인자가 중요하다고 알려져 있다.On the other hand, respiratory inflammatory diseases can be largely classified into rhinitis and sinusitis occurring in the upper airway, asthma and bronchitis in the lower respiratory tract, bronchiolitis and emphysema in the small airways. Clinically, the disease causes airway obstruction, asthma is characterized by reversible airway obstruction, there are 350 million people worldwide, about 2.3 million patients in Korea. Chronic obstructive pulmonary disease (COPD) is characterized by irreversible airway obstruction. Chronic obstructive bronchitis, chronic obstructive bronchiolitis, emphysema and the like are the causes of chronic obstructive pulmonary disease. In relation to the causes of inflammatory respiratory diseases, protein antigens (allergens) present in indoor air are known to be important in asthma, and stimulating factors such as smoking are known to be important in the cause of chronic obstructive pulmonary disease.

나아가 염증이 암을 일으킨다는 사실은 오래전부터 제기되었고, 최근에는 장내에 서식하는 세균에서 유래한 독소에 대한 Th17 면역반응에 의해 대장암이 발생한다고 보고되었으며, 위에 공생한다고 알려진 헬리코박터 파일로리(Helicobacter pylori) 균에 의해서 만성 위염이 발생하고, 이는 위암 발생의 중요한 위험인자로 보고되었다. 만성폐쇄성폐질환과 폐암의 병인과 관련해서 두 가지 질병은 동일한 원인인자에 의해 발생한다고 제시되고 있고, 두 질환의 원인인자로 흡연이 중요하다고 알려져 있으나, 최근 임상연구에서는 흡연과 상관없이 만성폐쇄성폐질환 자체가 폐암 발생의 중요한 위험인자라는 사실이 보고되었다. 또한, 비흡연자에서 발생하는 만성폐쇄성폐질환과 폐암이 다수 존재한다는 사실은 흡연 이외에도 이 두 가지 질환을 일으키는 원인인자가 존재함을 알 수 있다. The fact that further inflamed causing cancer has been raised for a long time, most recently by the Th17 immune response to the derived toxins from the bacteria that inhabit the intestine has been reported that the occurrence of colorectal cancer, also known as Helicobacter pylori that symbiotic above (Helicobacter pylori) Chronic gastritis is caused by bacteria, and it has been reported as an important risk factor of gastric cancer. In relation to the pathogenesis of chronic obstructive pulmonary disease and lung cancer, it is suggested that the two diseases are caused by the same cause factor, and smoking is important as the cause of both diseases. It has been reported that the disease itself is an important risk factor for the development of lung cancer. In addition, the fact that there are a large number of chronic obstructive pulmonary disease and lung cancer occurring in non-smokers can be seen that there are factors that cause these two diseases in addition to smoking.

하지만 천식과 더불어 만성폐쇄성폐질환 및 폐암 발병에 있어서, 실내 먼지 속에 포함된 세균 유래 세포밖 소포체가 미치는 영향 및 상기 질환들의 원인인자로써 실내 먼지 내 세포밖 소포체 유래 세균을 동정하고 이를 이용하여 질환을 진단하는 방법에 대해서는 보고된 바가 없다. However, in the development of chronic obstructive pulmonary disease and lung cancer in addition to asthma, the effects of bacteria-derived extracellular vesicles contained in indoor dust and the causes of the above diseases are identified and used to identify diseases derived from extracellular vesicles in indoor dust. No method of diagnosis has been reported.

상기와 같은 과제를 해결하기 위해, 본 발명자들은 메타게놈 분석을 통하여 실내 먼지에서 분리한 세균 유래 세포밖 소포체에서 천식, 만성폐쇄성폐질환, 폐암 발병의 원인인자로 작용할 수 있는 세균들을 동정함으로써 본 발명을 완성하였다. In order to solve the above problems, the present invention by identifying the bacteria that can act as a causative agent of asthma, chronic obstructive pulmonary disease, lung cancer in bacteria-derived extracellular vesicles isolated from the indoor dust through a metagenome analysis Was completed.

이에, 본 발명은 실내 먼지에 포함된 세균 유래 세포밖 소포체 또는 이 소포체 유래 단백질을 이용하여 천식, 만성폐쇄성폐질환, 및 폐암을 진단하기 위한 방법을 제공하는 것을 목적으로 한다. Accordingly, an object of the present invention is to provide a method for diagnosing asthma, chronic obstructive pulmonary disease, and lung cancer using bacterial extracellular vesicles or proteins derived from the endoplasmic reticulum contained in indoor dust.

그러나 본 발명이 이루고자 하는 기술적 과제는 이상에서 언급한 과제에 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다.However, the technical problem to be achieved by the present invention is not limited to the above-mentioned problem, another task that is not mentioned will be clearly understood by those skilled in the art from the following description.

상기와 같은 목적을 달성하기 위하여, 본 발명은 하기의 단계를 포함하는, 호흡기 염증성 질환의 진단방법을 제공한다. In order to achieve the above object, the present invention provides a method for diagnosing a respiratory inflammatory disease, comprising the following steps.

(A) 환자샘플을 실내먼지 세균 유래의 세포밖 소포체 또는 이 소포체 유래 단백질과 반응시키는 단계; (A) reacting a patient sample with extracellular vesicles or proteins derived from indoor dust bacteria;

(B) 상기 반응물에 항-인간 IgG 항체를 반응시켜 샘플내 IgG 항체의 양을 측정하는 단계; 및(B) reacting the reactant with an anti-human IgG antibody to determine the amount of IgG antibody in the sample; And

(C) 상기 샘플내 IgG 항체의 양이 정상인에 비하여 2배 이상 증가되어 있을 경우 호흡기 염증성 질환으로 판정하는 단계.(C) determining the respiratory inflammatory disease when the amount of IgG antibody in the sample is more than doubled compared to the normal person.

본 발명의 일 구현예로, 상기 세포밖 소포체 및 단백질은 포도상구균(Staphylococcus), 아시네토박터(Acinetobacter), 슈도모나스(Pseudomonas) 및 엔테로박터(Enterobacter)로 이루어진 군에서 선택되는 1종 이상의 균에서 유래되는 것일 수 있다. In one embodiment, the extracellular vesicles, and proteins Staphylococci (Staphylococcus), Acinetobacter (Acinetobacter), Pseudomonas (Pseudomonas) and Enterobacter (Enterobacter) derived from one or more bacteria selected from the group consisting of It may be.

본 발명의 다른 구현예로, 상기 포도상구균은 황색포도상구균(Staphylococcus aureus)이고, 상기 아시네토박터는 아시네토박터 바우마니(Acinetobacter baumannii)이고, 상기 슈도모나스는 녹농균(Pseudomonas aeruginosa)이고, 상기 엔테로박터는 엔테로박터 에어로게네스(Enterobacter aerogenes)일 수 있다. In another embodiment, the Staphylococcus aureus is Staphylococcus aureus , the Acinetobacter is Acinetobacter baumannii , and the Pseudomonas aeruginosa is Pseudomonas aeruginosa , May be Enterobacter aerogenes .

본 발명의 또 다른 구현예로, 상기 환자샘플은 혈액 및 객담으로 이루어진 군에서 선택되는 것일 수 있다. In another embodiment of the present invention, the patient sample may be selected from the group consisting of blood and sputum.

본 발명의 또 다른 구현예로, 상기 IgG 항체는 IgG1 또는 IgG4일 수 있다.In another embodiment of the invention, the IgG antibody may be IgG1 or IgG4.

본 발명의 또 다른 구현예로, 상기 세포밖 소포체는 평균 직경이 10-300 nm인 것을 특징으로 한다. In another embodiment of the present invention, the extracellular vesicles are characterized in that the average diameter of 10-300 nm.

본 발명의 또 다른 구현예로, 상기 호흡기 염증성 질환은, 천식, 만성폐쇄성폐질환, 및 폐암으로 이루어진 군에서 선택되는 것일 수 있다.In another embodiment of the present invention, the respiratory inflammatory disease may be selected from the group consisting of asthma, chronic obstructive pulmonary disease, and lung cancer.

또한, 본 발명은 실내먼지 세균 유래 세포밖 소포체의 호흡기 염증성 질환의 진단용도를 제공한다. In addition, the present invention provides a diagnostic use of respiratory inflammatory diseases of indoor dust bacteria-derived extracellular vesicles.

실내 공기의 먼지에 다량으로 존재하는 포도상구균(Staphylococcus), 아시네토박터(Acinetobacter), 슈도모나스(Pseudomonas), 및 엔테로박터(Enterobacter) 속 세균 유래 세포밖 소포체는 호흡기 염증성 질환을 유발할 수 있으므로, 본 발명은 환자 샘플내 상기 세균 유래 세포밖 소포체 또는 이 소포체 유래 단백질에 대한 특이 항체를 측정함으로써 천식, 만성폐쇄성폐질환, 폐암을 진단하기 위한 방법으로 유용하게 이용할 수 있다. Staphylococcus aureus present in a large quantity in dust in the room air (Staphylococcus), Acinetobacter (Acinetobacter), Pseudomonas (Pseudomonas), and Enterobacter (Enterobacter) in germ cells derived from outside the ER because it can lead to respiratory inflammatory diseases, the present invention It can be usefully used as a method for diagnosing asthma, chronic obstructive pulmonary disease and lung cancer by measuring the antibody-specific extracellular vesicles or specific antibodies to the vesicle-derived proteins in a patient sample.

도 1은, 계절별로 실내 먼지를 수거하여 세포밖 소포체를 분리한 후 소포체 양을 정량한 결과이다.1 is a result of quantifying the endoplasmic reticulum after separating the extracellular vesicles by collecting indoor dust seasonally.

도 2는, 계절별로 실내 먼지에서 분리한 세포밖 소포체의 형태를 전자현미경을 통해 관찰한 결과이다.2 is a result of observing the morphology of the extracellular vesicles separated from the indoor dust seasonally through an electron microscope.

도 3은, 계절별로 실내 먼지에서 분리한 세포밖 소포체의 크기를 동적광산란법으로 측정한 결과이다.3 is a result of measuring the size of the extracellular vesicles separated from the indoor dust seasonally by dynamic light scattering method.

도 4는, 계절별로 실내 먼지에서 분리한 세균 및 세포밖 소포체의 분포를 메타게놈 분석을 통해 문(phylum) 수준에서 분석한 결과이다.4 is a result of analyzing the distribution of bacteria and extracellular vesicles separated from the indoor dust seasonally at the phylum level through a metagenomic analysis.

도 5는, 계절별로 실내 먼지에서 분리한 세균 및 세포밖 소포체의 분포를 메타게놈 분석을 통해 속(genus) 수준에서 분석한 결과이다.5 is a result of analyzing the distribution of bacteria and extracellular vesicles separated from the indoor dust seasonally at the genus level through a metagenomic analysis.

도 6은, 정상인(Control), 천식환자(Asthma), 만성폐쇄성폐질환자(COPD), 폐암환자(Lung cancer)의 혈액 및 객담 샘플에서 측정한 실내 먼지 내 세포밖 소포체 특이 IgG 항체의 분포와 양성률을 나타낸 결과이다.FIG. 6 shows the distribution and the positive rate of extracellular vesicle-specific IgG antibodies in indoor dust measured from blood and sputum samples of control, asthma, chronic obstructive pulmonary disease (COPD), lung cancer patients (Lung cancer). Is the result.

도 7은, 세포밖 소포체 특이 IgG 항체가 양성을 나타낸 정상인(Control), 천식환자(Asthma), 만성폐쇄성폐질환자(COPD), 폐암환자(Lung cancer)에서 각 세균 유래 세포밖 소포체에 감작된 개수의 분포를 나타낸 그림이다.Figure 7 shows the number of sensitized to each bacteria-derived extracellular vesicles in the control group (Asthma), chronic obstructive pulmonary disease (COPD), lung cancer patients (positive) showed positive extracellular vesicle-specific IgG antibody This figure shows the distribution of.

도 8은, 세포밖 소포체 특이 IgG1 항체가 양성을 나타낸 정상인(Control), 천식환자(Asthma), 만성폐쇄성폐질환자(COPD), 폐암환자(Lung cancer)에서 세균 유래 세포밖 소포체에 감작된 개수의 분포를 나타낸 그림이다.FIG. 8 shows the number of sensitized bacteria-derived extracellular vesicles in normal, control, asthma, chronic obstructive pulmonary disease (COPD), and lung cancer patients with positive extracellular vesicle-specific IgG1 antibodies. Figure shows the distribution.

도 9는, 세포밖 소포체 특이 IgG4 항체가 양성을 나타낸 정상인(Control), 천식환자(Asthma), 만성폐쇄성폐질환자(COPD), 폐암환자(Lung cancer)에서 세균 유래 세포밖 소포체에 감작된 개수의 분포를 나타낸 그림이다.FIG. 9 shows the number of sensitized bacteria-derived extracellular vesicles in normal, control, asthma, chronic obstructive pulmonary disease (COPD), and lung cancer patients with positive extracellular vesicle-specific IgG4 antibodies. Figure shows the distribution.

본 발명은 실내 먼지에 존재하여 호흡기 염증성 질환을 유발하는 세균 유래 세포밖 소포체 또는 이 소포체 유래 단백질을 이용하여 천식, 만성폐쇄성폐질환, 폐암을 진단하는 방법에 관한 것이다. The present invention relates to a method for diagnosing asthma, chronic obstructive pulmonary disease, and lung cancer using a bacterial-derived extracellular vesicle or a protein derived from the endoplasmic reticulum present in indoor dust causing respiratory inflammatory disease.

본 발명에서는 실내 먼지에 존재하여 염증성 호흡기질환을 유발하는 세균 유래 세포밖 소포체의 특성을 평가하고 세포밖 소포체의 원인인자(세균)를 동정하였다. In the present invention, the characteristics of bacteria-derived extracellular vesicles present in indoor dust causing inflammatory respiratory diseases were evaluated and the causative factors (bacteria) of extracellular vesicles were identified.

본 발명의 일 실시예에서는, 실내 먼지에서 분리한 세포밖 소포체의 DNA를 분리한 후 메타게놈 분석을 수행하여 세균 및 세균 유래 세포밖 소포체의 분포를 분석하였다. 세균 문(phylum level) 수준에서 분석한 결과, 사계절 모든 경우 실내 먼지에는 그람 음성균인 프로테오박테리아(Proteobacteria) 문 세균과 그람 양성균인 후벽균(Firmicutes) 문 세균이 대부분을 차지하였다. 좀 더 구체적으로 속(genus level) 수준에서는 실내 먼지 속에 그람 음성균인 경우 프로테오박테리아(proteobacteria) 문에 속하는 슈도모나스(Pseudomonas) 속, 아시네토박터(Acinetobacter) 속, 엔테로박터(Enterobacter) 속, 레클레르시아(Leclercia) 속 세균, 그람 양성균인 경우 후벽균(Firmicutes) 문에 속하는 포도상구균(Staphylococcus) 속 세균이 사계절 모두에서 주를 이루는 것으로 분석되었다(실시예 3 참조).In one embodiment of the present invention, the DNA of the extracellular vesicles separated from the indoor dust was separated and then subjected to metagenomic analysis to analyze the distribution of bacteria and bacteria-derived extracellular vesicles. Bacterial Door (phylum level) analysis of the level, if any season indoor dust has accounted for the Gram-negative proteobacteria (Proteobacteria) statement bacteria and Gram-positive bacteria of Firmicutes (Firmicutes) Most doors bacteria. More specifically, in (genus level) at the level when the Gram-negative bacteria in indoor dust proteobacteria (proteobacteria) Pseudomonas (Pseudomonas) belonging to the door, Acinetobacter (Acinetobacter) genus, Enterobacter (Enterobacter), A Le Clerc cyano (Leclercia) in the bacteria, gram-positive when the Staphylococcus (Staphylococcus) in bacteria belonging to the Firmicutes (Firmicutes) gate were analyzed to achieve a state in all seasons (see example 3).

본 발명의 다른 실시예에서는, 실내 먼지 내에 존재하는 세균 유래 세포밖 소포체의 감작과 천식, 만성폐쇄성폐질환, 폐암과의 연관성을 평가하기 위해 상기 질병을 앓고 있는 3가지 환자 그룹과 정상인 그룹에서 샘플을 얻어 세포밖 소포체 특이 IgG 항체의 양을 측정하였다. 연관성 분석 결과, 정상인인 경우 4.4%, 천식환자인 경우 13.6%, 만성폐쇄성폐질환 환자인 경우 29.3%, 폐암환자인 경우 54.9%에서 세포밖 소포체에 감작되어 있음을 확인하였다(실시예 4 참조). In another embodiment of the present invention, samples from three patients and normal groups suffering from the disease to evaluate the sensitization of bacteria-derived extracellular vesicles present in indoor dust and its association with asthma, chronic obstructive pulmonary disease, and lung cancer The amount of extracellular vesicle-specific IgG antibody was obtained. Correlation analysis revealed that 4.4% of normal subjects, 13.6% of asthmatic patients, 29.3% of patients with chronic obstructive pulmonary disease, and 54.9% of lung cancer patients were sensitized to extracellular vesicles (see Example 4). .

또한 multiple logistic regression analysis을 통하여 세포밖 소포체에의 감작 또는 흡연과 상기 질환들과의 연관성을 평가한 결과, 천식의 경우에는 세포밖 소포체에 감작된 경우 감작되지 않은 사람에 비하여 발생위험이 3.3배 증가하였으며, 흡연자의 경우 비흡연자에 비하여 오히려 발생위험이 감소하였다. 만성폐쇄성폐질환의 경우, 세포밖 소포체에 감작된 경우 그렇지 않은 경우에 비하여 발생위험이 8.0배 증가하였고, 흡연자의 경우 3.7배 증가하였다. 폐암의 경우에는 세포밖 소포체에 감작된 경우 발생위험이 감작되지 않은 경우에 비하여 38.7배 증가하였고, 흡연을 하는 경우에는 2.7배 증가함을 확인하였다. 따라서 세포밖 소포체에 대한 감작이 흡연의 경우보다 현저히 높은 위험성을 가지며 질환의 발병을 유도할 수 있음을 확인하였다(실시예 5 참조).In addition, as a result of evaluating the association between extracellular vesicle sensitization or smoking and multiple diseases through multiple logistic regression analysis, the incidence of asthma was 3.3 times higher than that of non-sensitized individuals when sensitized to extracellular vesicles. Smokers were less likely to develop than non-smokers. In chronic obstructive pulmonary disease, the risk of extracellular vesicle sensitization was increased by 8.0 times and that of smokers was increased by 3.7 times. In the case of lung cancer, the incidence of sensitization to extracellular vesicles was increased by 38.7 times compared with the case without sensitization, and by 2.7 times when smoking. Therefore, it was confirmed that the sensitization to extracellular vesicles has a significantly higher risk than that of smoking and induces the onset of the disease (see Example 5).

본 발명의 또 다른 실시예에서는, 상기 실시예 3에서 동정한 포도상구균(Staphylococcus), 아시네토박터(Acinetobacter), 슈도모나스(Pseudomonas), 엔테로박터(Enterobacter) 속 세균에 해당하는 각각의 황색포도상구균(Staphylococcus aureus), 아시네토박터 바우마니(Acinetobacter baumannii), 녹농균(Pseudomonas aeruginosa), 및 엔테로박터 에어로게네스(Enterobacter aerogenes)에서 세포밖 소포체를 분리하여 이에 대한 상기 각 그룹의 세포밖 소포체 특이 IgG, IgG1, IgG4 항체를 측정하였다. 황색포도상구균(Staphylococcus aureus) 유래 세포밖 소포체 감작과 천식, 만성폐쇄성폐질환, 폐암의 연관성을 평가한 결과, 각각 3.0배, 12.6배, 11.2배 발생위험이 증가하는 것으로 나타났다. 아시네토박터 바우마니(Acinetobacter baumannii) 유래 세포밖 소포체에의 감작하는 경우, 천식, 만성폐쇄성폐질환, 폐암의 발생위험은 각각 2.2배, 6.3배, 8.0배 증가하였다. 녹농균(Pseudomonas aeruginosa) 유래 세포밖 소포체에 감작하는 경우에는 각각 6.2배. 4.5배, 17.5배로 천식, 만성폐쇄성폐질환, 폐암의 발생위험이 증가하였으며, 엔테로박터 에어로게네스(Enterobacter aerogenes) 유래 세포밖 소포체에 감작하는 경우에는 2.4배, 2.8배, 8.3배로 천식, 만성폐쇄성폐질환, 폐암의 발생위험이 증가하는 것으로 나타났다(실시예 6 참조). In another embodiment of the invention, the above-described one staphylococci (Staphylococcus), Acinetobacter (Acinetobacter), Pseudomonas (Pseudomonas), Enterobacter each of Staphylococcus aureus for the (Enterobacter) in bacteria isolated from Example 3 ( Staphylococcus aureus ), Acinetobacter extracellular vesicles were isolated from baumannii ), Pseudomonas aeruginosa , and Enterobacter aerogenes , and the extracellular vesicle specific IgG, IgG1, IgG4 antibodies of each group were measured. The association of extracellular vesicle sensitization with Staphylococcus aureus, asthma, chronic obstructive pulmonary disease, and lung cancer was evaluated to increase the risk of developing 3.0, 12.6, and 11.2 times, respectively. Acinetobacter The risk of asthma, chronic obstructive pulmonary disease, and lung cancer was increased by 2.2, 6.3, and 8.0 times, respectively. Pseudomonas aeruginosa ) 6.2 times each when sensitized to extracellular vesicles. The risk of asthma, chronic obstructive pulmonary disease, and lung cancer increased by 4.5 and 17.5 times, and Enterobacter When sensitized to aerogenes- derived extracellular vesicles, the risk of asthma, chronic obstructive pulmonary disease, and lung cancer was increased by 2.4, 2.8, and 8.3 times (see Example 6).

본 발명의 또 다른 실시예에서는, 상기 네 가지 세균 유래 세포밖 소포체에 감작 개수와 천식, 만성폐쇄성폐질환, 폐암의 연관성을 분석하였다. 소포체 특이 IgG 항체를 측정한 경우 천식, 만성폐쇄성폐질환, 그리고 폐암환자에서 모두 3가지 이상 세균 유래 소포체에 대해 증가하였고, IgG1의 경우에는 만성폐쇄성폐질환과 폐암환자에서만 4가지 세균 유래 소포체 모두에 대해서 증가하였다. IgG4의 경우에는 폐암 환자에서 2가지 혹은 3가지 세균 유래 소포체에 대해 증가함을 확인하였다(실시예 7 참조).In another embodiment of the present invention, the association between the number of sensitization and asthma, chronic obstructive pulmonary disease, lung cancer in the four bacteria-derived extracellular vesicles. Anti-vesicle-specific IgG antibodies were measured for at least three bacterial-derived vesicles in asthma, chronic obstructive pulmonary disease, and lung cancer patients. For IgG1, all four bacterial-derived vesicles were found in chronic obstructive pulmonary disease and lung cancer patients only. Increased. In the case of IgG4, it was confirmed that two or three bacteria-derived vesicles increased in lung cancer patients (see Example 7).

본 발명에서 사용되는 용어, ‘메타게놈’이란 '군유전체'라고도 하며, 흙, 동물의 장 등 고립된 지역 내의 모든 바이러스, 세균, 곰팡이 등을 포함하는 유전체의 총합을 의미하는 것으로, 주로 배양이 되지 않는 미생물을 분석하기 위해서 서열분석기를 사용하여 한꺼번에 많은 미생물을 동정하는 것을 설명하는 유전체의 개념으로 쓰인다. 특히, 메타게놈은 한 종의 게놈, 유전체를 말하는 것이 아니라, 한 환경단위의 모든 종의 유전체로서 일종의 혼합유전체를 말한다. 이는 오믹스적으로 생물학이 발전하는 과정에서 한 종을 정의할 때 기능적으로 기존의 한 종뿐만 아니라, 다양한 종이 서로 상호작용하여 완전한 종을 만든다는 관점에서 나온 용어이다. 기술적으로는 빠른 서열분석법을 이용해서, 종에 관계없이 모든 DNA, RNA를 분석하여, 한 환경 내에서의 모든 종을 동정하고, 상호작용, 대사작용을 규명하는 기법의 대상이다. The term 'metagenome' used in the present invention, also referred to as 'gunoelectric', refers to the sum total of the genome including all viruses, bacteria, fungi, etc. in an isolated area such as soil and animal intestine. It is used as a concept of genome explaining the identification of many microorganisms at once using sequencer to analyze microorganisms that are not. In particular, the metagenome does not refer to one genome or genome, but to a kind of mixed dielectric as the genome of all species of one environmental unit. This is a term from the point of view of defining a species in the course of the evolution of biology in terms of functional species as well as various species that interact with each other to create a complete species. Technically, rapid sequencing is used to analyze all DNA and RNA, regardless of species, to identify all species in one environment, and to identify interactions and metabolism.

본 발명은 환자샘플을 실내먼지 세균 유래의 세포밖 소포체 또는 이 소포체 유래 단백질과 반응시키는 단계; 상기 반응물에 항-인간 IgG 항체를 반응시켜 샘플내 IgG 항체의 양을 측정하는 단계; 및 상기 샘플내 IgG 항체의 양이 정상인에 비하여 2배 이상 증가되어 있을 경우 호흡기 염증성 질환으로 판정하는 단계를 포함하는 호흡기 염증성 질환의 진단방법을 제공한다. The present invention comprises the steps of reacting a patient sample with extracellular vesicles or proteins derived from the indoor dust bacteria; Reacting the reaction with an anti-human IgG antibody to determine the amount of IgG antibody in the sample; And it provides a method for diagnosing respiratory inflammatory disease comprising the step of determining the respiratory inflammatory disease when the amount of IgG antibody in the sample is increased more than two times compared to the normal person.

본 발명에서 사용되는 용어, “세포밖 소포체”는 다양한 세균에서 분비되는 나노크기의 나노소포체를 의미한다. 실내 먼지에 존재하는 세포밖 소포체는 실내에 서식하고 있는 세균, 집먼지 진드기, 바퀴, 애완동물, 인간 등을 포함한 다양한 생명체에 서식하거나 건축물을 포함한 구조물의 내부와 주변에 서식하는 여러 종류의 세균에 의해 생성될 수 있으며, 상기 세포밖 소포체는 평균 직경이 10-300 nm일 수 있으나, 이에 제한되는 것은 아니다. As used herein, the term “extracellular vesicles” refers to nanoscale nanovesicles secreted by various bacteria. The extracellular vesicles present in the indoor dust are caused by bacteria living in the room, house dust mites, wheels, pets, humans, etc., or by various kinds of bacteria living in and around structures including structures. The extracellular vesicles may be produced, but the average diameter may be 10-300 nm, but is not limited thereto.

본 발명에서는 상기 세포밖 소포체를 대신해 항원으로써 세포밖 소포체에 포함된 단백질을 이용할 수 있으나, 이에 제한되는 것은 아니다. In the present invention, a protein contained in the extracellular vesicles may be used as an antigen instead of the extracellular vesicles, but is not limited thereto.

본 발명의 상기 세포밖 소포체 및 이 소포체 유래 단백질은 포도상구균(Staphylococcus), 아시네토박터(Acinetobacter), 슈도모나스(Pseudomonas) 및 엔테로박터(Enterobacter)로 이루어진 군에서 선택되는 1종 이상의 균에서 유래될 수 있고, 바람직하게는 포도상구균은 황색포도상구균(Staphylococcus aureus)이고, 상기 아시네토박터는 아시네토박터 바우마니(Acinetobacter baumannii)이고, 상기 슈도모나스는 녹농균(Pseudomonas aeruginosa)이고, 상기 엔테로박터는 엔테로박터 에어로게네스(Enterobacter aerogenes)일 수 있으나, 이에 제한되는 것은 아니다. The cell outside the ER and the ER-derived protein of the present invention are Staphylococcus aureus (Staphylococcus), Acinetobacter (Acinetobacter), Pseudomonas (Pseudomonas) and Enterobacter (Enterobacter) may be derived from one strain or more kinds selected from the group consisting of Preferably, staphylococcus aureus is Staphylococcus aureus , the acinetobacter is Acinetobacter Baumani ( Acinetobacter) baumannii ), and the pseudomonas is Pseudomonas aeruginosa ), the enterobacter may be Enterobacter aerogenes , but is not limited thereto.

본 발명의 상기 환자샘플은 혈액 및 객담으로 이루어진 군에서 선택되는 것일 수 있으나, 이에 제한되는 것은 아니다. The patient sample of the present invention may be selected from the group consisting of blood and sputum, but is not limited thereto.

본 발명의 상기 항체는 IgG, IgA, 또는 IgE일 수 있으며, IgG 항체는 IgG1 또는 IgG4일 수 있으나, 이에 제한되는 것은 아니다. The antibody of the present invention may be IgG, IgA, or IgE, IgG antibody may be IgG1 or IgG4, but is not limited thereto.

본 발명의 상기 호흡기 염증성 질환은 천식, 만성폐쇄성폐질환, 및 폐암으로 이루어진 군에서 선택될 수 있으나, 이에 제한되는 것은 아니다. The respiratory inflammatory disease of the present invention may be selected from the group consisting of asthma, chronic obstructive pulmonary disease, and lung cancer, but is not limited thereto.

이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나 하기의 실시예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 하기 실시예에 의해 본 발명의 내용이 한정되는 것은 아니다.Hereinafter, preferred examples are provided to aid in understanding the present invention. However, the following examples are merely provided to more easily understand the present invention, and the contents of the present invention are not limited by the following examples.

[[ 실시예Example ]]

실시예Example 1.  One. 세포밖Extracellular 소포체 추출 Vesicular Extract

실내 공기에 존재하는 세포밖 소포체의 특성, 농도, 메타게놈 분석을 위해 봄(Spring), 여름(Summer), 가을(Fall), 겨울(Winter) 계절별로 서울에 있는 두 개의 아파트에 있는 침대 매트리스에서 먼지를 포집하여 세포밖 소포체를 분리, 동정하는 실험을 수행하였다. To analyze the characteristics, concentrations, and metagenomics of extracellular vesicles in indoor air, the bed mattresses of two apartments in Seoul by spring, summer, fall, and winter seasons. The experiment was performed to isolate and identify extracellular vesicles by collecting dust.

구체적으로, 진공청소기를 사용해 침대 매트리스에 존재하는 먼지를 수거한 후 진공청소기의 필터 내에 존재하는 먼지를 깨끗한 유리병에 옮겨 담고 질량을 측정하였다. 실내 먼지 5 g을 200 ㎖의 PBS(phosphate-buffered saline)가 들어있는 비커에 넣고 4℃에서 12시간 동안 녹여내었다. 이후 일차적으로 거즈를 이용하여 큰 이물질들을 걸러내고, 걸러져 나온 용액을 고속원심분리 튜브(high speed centrifuge tube)에 나눠 담은 후, 4℃, 10,000 x g에서 15분 동안 고속원심분리(high speed centrifugation)를 연속으로 2번 수행하였다. 180 ㎖ 가량의 상층액을 구멍 직경이 0.45 μm인 멤브레인 필터(membrane filter)에 1회 통과시킨 후, 걸러진 상층액을 70 ㎖ 용량의 초원심분리 튜브(ultracentrifuge tube)에 나눠 담고 4℃, 100,000 x g에서 4시간 동안 초원심분리(ultracetrifugation)를 수행하였다. 상층액은 버리고 튜브 아래에 존재하는 침전물을 PBS로 녹여 세포밖 소포체를 추출하였다. Specifically, after collecting the dust present in the bed mattress using a vacuum cleaner, the dust present in the filter of the vacuum cleaner was transferred to a clean glass bottle to measure the mass. 5 g of indoor dust was placed in a beaker containing 200 ml of PBS (phosphate-buffered saline) and dissolved at 4 ° C. for 12 hours. Afterwards, the large amount of foreign matter is first filtered out, the filtered solution is divided into high speed centrifuge tubes, and high speed centrifugation is performed at 10,000 xg for 15 minutes at 4 ° C. Performed twice in succession. After passing about 180 mL of the supernatant through a membrane filter having a pore diameter of 0.45 μm, the filtered supernatant was divided into a 70 mL ultracentrifuge tube, and then stored at 4 ° C., 100,000 xg. The ultracentrifugation (ultracetrifugation) was performed for 4 hours at. The supernatant was discarded and the extracellular vesicles were extracted by dissolving the precipitate under the tube with PBS.

그 결과, 도 1에 나타낸 바와 같이, 봄, 여름, 가을, 겨울에 두 아파트 침대 매트리스에서 분리한 먼지에는 각각 115.6, 83.8, 71.3, 96.1 ㎍(protein/g dust)의 세포밖 소포체가 포함되어 있음을 확인하였다.As a result, as shown in Figure 1, the dust separated from the two mattress bed mattress in spring, summer, autumn and winter contains 115.6, 83.8, 71.3, 96.1 ㎍ (protein / g dust) extracellular vesicles, respectively It was confirmed.

실시예Example 2. 실내 먼지에서 분리한  2. Separated from indoor dust 세포밖Extracellular 소포체의 특성 평가 Characterization of endoplasmic reticulum

실시예 1의 방법으로 분리한 세포밖 소포체의 특성을 평가하기 위하여 투과전자현미경(transmission electron microscopy; TEM)을 통해 세포밖 소포체를 관찰하였다. 침대 매트리스 먼지에서 분리한 세포밖 소포체를 10 ㎍/㎖ 농도로 희석한 후, 10 ㎕를 400-메쉬 구리 그리드(mesh copper grids)에 안착시켰다. 이후 2% 우라닐아세테이트(uranyl acetate)로 염색하고 수분을 날린 후 JEM1011 현미경(JEOL, Peabody, MA, USA)을 이용하여 100 kV 조건하에서 관찰하였다. The extracellular vesicles were observed by transmission electron microscopy (TEM) to evaluate the properties of the extracellular vesicles separated by the method of Example 1. After diluting the extracellular vesicles separated from the bed mattress dust to a concentration of 10 μg / ml, 10 μl was placed on 400-mesh copper grids. After staining with 2% uranyl acetate (uranyl acetate) and blowing water was observed under 100 kV using a JEM1011 microscope (JEOL, Peabody, MA, USA).

그 결과, 도 2에 나타낸 바와 같이, 봄, 여름, 가을, 겨울에 분리한 먼지 내에 동그란 모양의 소포체가 함유되어 있음을 확인하였다.As a result, as shown in Figure 2, it was confirmed that the round endoplasmic reticulum contained in the dust separated in the spring, summer, autumn, winter.

다음으로 동적 광산란법(dynamic light scattering)을 통하여 침대 매트리스 먼지에서 분리한 세포밖 소포체의 크기를 측정하였다. 상기 세포밖 소포체를 10 ㎍/㎖ 농도로 희석한 후, 1 ㎖을 큐벳(cuvette)에 넣고 Zetasizer Nano S(Malvern Instrument Ltd. Worcestershire, UK)를 이용하여 633 nm 파장에서 광산란 정도를 측정하였다(30초 x 10회/sample). Next, the size of the extracellular vesicles separated from the bed mattress dust was measured by dynamic light scattering. After diluting the extracellular endoplasmic reticulum to 10 ㎍ / ㎖ concentration, 1 mL into the cuvette (cuvette) and measured the degree of light scattering at 633 nm wavelength using Zetasizer Nano S (Malvern Instrument Ltd. Worcestershire, UK) (30 X 10 times / sample).

그 결과, 도 3에 나타낸 바와 같이, 봄, 여름, 가을 및 겨울에 침대 매트리스 먼지에서 분리한 세포밖 소포체의 크기는 각각 30-220, 20-100, 30-220 그리고 50-250 nm로 나타났다.As a result, as shown in Figure 3, the size of the extracellular vesicles separated from the bed mattress dust in spring, summer, autumn and winter was 30-220, 20-100, 30-220 and 50-250 nm, respectively.

실시예Example 3. 실내 먼지에 존재하는 세균 및 세균 유래  3. Germs and germ origin present in indoor dust 세포밖Extracellular 소포체  Endoplasmic reticulum 메타게Metage 놈(metagenome) 분석Metagenome analysis

실내 먼지에 존재하는 세균 및 세포밖 소포체로부터 DNA를 추출하여 메타게놈분석을 수행하여 세균 및 세균 유래 세포밖 소포체의 분포를 문 수준(phylum level) 및 속 수준(genus level)으로 분석하였다. DNA was extracted from bacteria and extracellular vesicles present in the indoor dust and subjected to metagenomic analysis to analyze the distribution of bacteria and bacteria-derived extracellular vesicles at the phylum level and genus level.

구체적으로, 실내 먼지에 존재하는 세균 및 세포밖 소포체에서 DNA 추출 kit (Bioneer Inc., Daejeon, Korea)를 이용하여 DNA를 추출하여 얻었으며, DNA 라이브러리는 GS FLX titanium library prep guide에 따라 제작하였다. 이후 제작 라이브러리는 Picogreen assay(Invitrogen, Carlsbad, CA, USA)를 이용하여 정량하였으며, 제작 라이브러리 증폭을 위해 에멀젼 PCR(emulsion PCR; emPCR)을 GSFLX titanium emPCR Kit(454 Life Sciences, Basel, Switzerland)를 이용하여 수행하였다. 제작 라이브러리를 비드(bead) 위에 고정한 후, amplification mix 및 오일과 섞어 Tissue Lyser II(Qiagen, Limburg, Netherlands)에서 격렬하게 섞은 후 “micro-reactors”를 형성하고, 유액은 96-well plate에 분주 후 PCR 증폭반응을 수행하였다. 분리한 DNA의 유전자 염기서열 분석을 위해 상기의 방법으로 분리한 DNA를 중합효소 연쇄반응을 통해 증폭한 후, 화학적으로 에멀젼 상태를 깨고 필터를 통해 증폭된 라이브러리가 붙어있는 bead를 분리하였다. 이후 스트렙타비딘이 코팅된 마그네틱 비드(streptavidin-coated magnetic beads)에 붙을 수 있는 biotinylated primer A(complementary to adaptor A)를 이용하여 증폭된 라이브러리가 붙어있는 비드만을 정제하였다. 다음으로 열에 의한 DNA 이중나선 분리를 통해 비드에 붙어있는 단일 가닥의 주형 DNA 단편들로 만들었다. 이후, 분리한 주형 단일가닥 DNA에 시퀀싱(sequencing)용 프라이머를 붙이고, particle counter(Beckman Coulter, Brea, CA, USA)를 이용하여 비드의 수를 측정하였다. Genome Sequencer FLX titanium sequencer(454 Life Sciences)를 이용하여 시퀀싱을 수행하였으며, 각 샘플은 8 레인 개스킷이 장착된 70-75-mm PicoTiter plate(454 Life Sciences)의 한 부분에 넣어주었다.Specifically, DNA was extracted from the bacterial and extracellular vesicles present in the indoor dust using a DNA extraction kit (Bioneer Inc., Daejeon, Korea), and the DNA library was prepared according to the GS FLX titanium library prep guide. Subsequently, the production library was quantified using Picogreen assay (Invitrogen, Carlsbad, CA, USA), and emulsion PCR (emulsion PCR; emPCR) using GSFLX titanium emPCR Kit (454 Life Sciences, Basel, Switzerland) for amplification of the production library. It was performed by. The production library was fixed on the beads, mixed with an amplification mix and oil, mixed vigorously in Tissue Lyser II (Qiagen, Limburg, Netherlands) to form “micro-reactors”, and the fluid was dispensed on 96-well plates. PCR amplification reactions were performed. For DNA sequencing of the isolated DNA, the DNA isolated by the above method was amplified by a polymerase chain reaction, and then the bead containing the amplified library was separated through the filter by breaking the emulsion state. Then, only beads having amplified libraries were purified using biotinylated primer A (complementary to adapter A), which can be attached to streptavidin-coated magnetic beads (streptavidin-coated magnetic beads). Next, heat DNA double helix separation was used to create single-stranded template DNA fragments attached to the beads. Subsequently, sequencing primers were attached to the isolated template single-stranded DNA, and the number of beads was measured using a particle counter (Beckman Coulter, Brea, CA, USA). Sequencing was performed using the Genome Sequencer FLX titanium sequencer (454 Life Sciences), and each sample was placed in a portion of a 70-75-mm PicoTiter plate (454 Life Sciences) equipped with an eight lane gasket.

모든 시퀀스는 BLASTN 및 EzTaxon 데이터베이스를 이용하여 비교하였다. 시퀀스 중 유사하거나, 100 bit score 이상, 1.0 E-value 이하의 값을 가지는 것은 부분적인 16s rRNA로 간주하였다. 비 16S rRNA 시퀀스는 1% 미만으로 나타났다. 판독한 시퀀스는 EzTaxon 데이터베이스를 이용하여 분류학적으로 분류하였다. 각 시퀀스 판독을 위해 데이터베이스에서 가장 유사한 다섯 시퀀스를 bit score에 따라 BLASTN 프로그램에서 추출하였다. 이 다섯 시퀀스에서, ClustalW 프로그램을 사용하여 유사도를 측정하였으며, 읽어들인 시퀀스와 가장 높은 유사도를 보이는 시퀀스를 분류를 위해 사용하였다. 분류상, 속의 경우 94%, 문의 경우 75% 이상의 유사도 기준으로 분류하였다. All sequences were compared using the BLASTN and EzTaxon databases. Similar sequences, having a value above 100 bit score and below 1.0 E-value were considered partial 16s rRNA. Non 16S rRNA sequences were found to be less than 1%. Read sequences were classified taxonomically using EzTaxon database. For each sequence reading, the five most similar sequences from the database were extracted from the BLASTN program according to the bit score. In these five sequences, the similarity was measured using the ClustalW program, and the sequence with the highest similarity to the read sequence was used for classification. By classification, 94% of genus and 75% of inquiries were classified according to similarity criteria.

각 샘플별 세균 및 세균 유래 세포밖 소포체의 분포를 문 수준(phylum level)에서 분석한 결과, 도 4에 나타낸 바와 같이, 세균(Bacteria) 유래의 경우, 사계절 모두에서 그람 음성균인 프로테오박테리아(Proteobacteria) 문 세균이 95% 이상으로 나타났고, 그람 양성균으로 후벽균(Firmicutes), 방선균(Actinobacteria) 문 세균이 그 다음을 차지하였다. 먼지 내 세포밖 소포체(EV)인 경우, 사계절 모두 그람 음성균인 프로테오박테리아(Proteobacteria) 문 세균에서 유래하는 세포밖 소포체가 90% 이상을 차지하였고, 그람 양성균인 후벽균(Firmicutes) 문 세균 유래 세포밖 소포체가 그 다음을 차지하였다. As a result of analyzing the distribution of bacteria and bacteria-derived extracellular vesicles by each sample at the phylum level, as shown in FIG. 4, in the case of bacteria (Bacteria), gram-negative bacteria in all four seasons ( Proteobacteria) ) More than 95% of the bacteria were gram-positive bacteria, followed by Firmicutes and Actinobacteria . When the dust within the extracellular vesicles (EV), an extracellular vesicles derived from the four seasons all Gram-negative bacteria of proteobacteria (Proteobacteria) statement bacteria accounted for more than 90%, Gram-positive bacteria of Firmicutes (Firmicutes) statement bacteria-derived cells Outer vesicles came next.

또한, 먼지 내에 존재하는 세균 및 세균 유래 세포밖 소포체의 분포를 속 수준(genus level)에서 분석하였다. 그 결과, 도 5에 나타낸 바와 같이, 세균(Bacteria) 유래의 경우 그람 음성균인 경우에 Proteobacteria 문에 속하는 슈도모나스(Pseudomonas) 속, 아시네토박터(Acinetobacter) 속, 엔테로박터(Enterobacter) 속, 레클레르시아(Leclercia) 속 세균이 사계절 모두에서 주를 이루었고, 그람 양성균인 경우, Firmicutes 문에 속하는 포도상구균(Staphylococcus)속 세균이 사계절 모두에서 주를 이루었다. 먼지 속 세균 유래 세포밖 소포체 분포를 평가하였을 때, 그람 음성균인 경우에 역시 Proteobacteria 문에 속하는 슈도모나스(Pseudomonas) 속, 아시네토박터(Acinetobacter) 속, 엔테로박터(Enterobacter) 속, 레클레르시아(Leclercia) 속 세균이 사계절 모두에서 주를 이루었고, 그람 양성균인 경우, Firmicutes 문에 속하는 포도상구균(Staphylococcus) 속 세균이 사계절 모두에서 주를 이루는 것으로 나타났다. In addition, the distribution of bacteria and bacteria-derived extracellular vesicles present in the dust was analyzed at the genus level. As a result, as shown in FIG. 5, the bacteria (Bacteria) derived in the case of Pseudomonas (Pseudomonas) genus Acinetobacter (Acinetobacter) belonging to the Proteobacteria door in the case of gram-negative genus Enterobacter (Enterobacter), A Le Clerc cyano (Leclercia) in bacteria is achieved when the main yirueotgo, Gram-positive bacteria in the main all four seasons, Staphylococcus (Staphylococcus) in bacteria belonging to the Firmicutes door in all seasons. When evaluating the dust bacteria-derived extracellular vesicles distribution, also Pseudomonas (Pseudomonas) genus Acinetobacter (Acinetobacter) genus Enterobacter (Enterobacter), A Le Clerc cyano (Leclercia) belonging to the Proteobacteria door in the case of gram-negative bacteria If the bacteria in the yirueotgo a week in all seasons, gram-positive, show that the Staphylococcus aureus (Staphylococcus) in bacteria belonging to the Firmicutes door forming a week in all seasons.

실시예Example 4. 천식,  4. Asthma, 만성폐쇄성폐질환Chronic Obstructive Pulmonary Disease , 폐암 환자 샘플에서 실내 먼지 내 소포체 특이 IgG 항체 측정Of ER-specific IgG Antibodies in Indoor Dust in Patients with Lung Cancer

실내 먼지 내에 존재하는 세균 유래 세포밖 소포체 감작과 천식, 만성폐쇄성폐질환, 폐암과의 연관성을 평가하기 위하여, 4가지 그룹에서 혈액 및 객담에서 샘플을 준비하여 평가를 수행하였다. 첫 번째 그룹은 가역적 기도 폐색에 근거한 내과진단을 받은 294명의 천식(Asthma) 환자로 구성되었고, 두 번째 그룹은 흡연 이력에 관계없이 기관지 확장제 사용 후, 1초간 호기량/총폐활량(FEV1/FVC)이 0.7을 넘는 242명의 만성폐쇄성폐질환(chronic obstructive pulmonary disease; COPD) 환자로 이루어졌다. 세 번째 그룹은 2003년 11월부터 2011년 3월까지 단국대학교 병원에 폐암(Lung cancer)으로 진단받은 환자들로 구성되었으며, 네 번째 그룹은 대조군(Control)으로써 내과 건강진단 결과, 호흡기 질환이 없는 90명의 일반인으로 구성되었다. 상기 4가지 그룹을 하기 표 1에 자세히 나타내었다. In order to evaluate the association between bacterial-derived extracellular vesicle sensitization and asthma, chronic obstructive pulmonary disease, and lung cancer in indoor dust, samples were prepared from blood and sputum in four groups. The first group consisted of 294 Asthma patients who had undergone a medical diagnosis based on reversible airway obstruction.The second group had a 1-second expiratory volume / total lung capacity (FEV1 / FVC) after bronchodilator use regardless of smoking history. The study consisted of 242 patients with chronic obstructive pulmonary disease (COPD). The third group consisted of patients diagnosed with lung cancer at Dankook University Hospital from November 2003 to March 2011. The fourth group was the control group. It consists of 90 members of the public. The four groups are shown in detail in Table 1 below.

SubjectsSubjects ControlControl AsthmaAsthma COPDCOPD Lung cancerLung cancer Number of subjectsNumber of subjects 9090 294294 242242 325325 Age (years)*Age (years) * 51±1051 ± 10 55±1555 ± 15 66±766 ± 7 66±966 ± 9 Male, %Male,% 5757 4242 8888 8484 Cigarette smoker, %Cigarette smoker,% 5050 2727 8585 7575

*Mean±standard deviation* Mean ± standard deviation

실내 먼지에 존재하는 세포밖 소포체에 대한 감작유무를 평가하기 위하여 상기 환자 및 대조군에서 얻은 샘플에서 소포체 특이 IgG 항체를 측정하였다. 세포밖 소포체 특이 IgG 항체의 양을 측정하기 위해 50 ng의 세포밖 소포체를 96-well plate의 각 well에 하루 동안 안착시켰다. 세포밖 소포체 특이 IgG 항체의 정량을 위해 anti-human IgG 항체를 세포밖 소포체 대신 안착하였다. 다음날, 5% 탈지분유로 항체 및 세포밖 소포체 안착 간극을 메우고, 확보한 샘플을 5% 탈지분유에 1000배 희석하여 반응시켰다. 다음으로 홀스레디쉬 페록시다아제가 접합된 2차 항체(Horseradish peroxidase-conjugated anti-IgG)(abcam, Cambridge, UK)를 5% 탈지분유액에 희석하여 반응시킨 후, microplate reader를 통해 IgG 항체의 양을 측정하였다. 먼지 내 세포밖 소포체에 대한 감작은 정상인 샘플에 존재하는 소포체 특이 IgG 항체 값의 95% 이상을 보이는 경우에 양성으로 정의하였다. In order to evaluate the sensitization of extracellular vesicles present in indoor dust, vesicle-specific IgG antibodies were measured in samples obtained from the patients and controls. To measure the amount of extracellular vesicle-specific IgG antibodies, 50 ng of extracellular vesicles were placed in each well of a 96-well plate for one day. For quantification of extracellular vesicle-specific IgG antibodies, anti-human IgG antibodies were placed in place of extracellular vesicles. The next day, 5% skim milk powder filled the antibody and extracellular vesicle seating gap, and the obtained sample was reacted by diluting 1000-fold in 5% skim milk powder. Next, the horseradish peroxidase conjugated secondary antibody (Horseradish peroxidase-conjugated anti-IgG) (abcam, Cambridge, UK) was diluted in 5% skim milk solution, and then reacted with an IgG antibody through a microplate reader. The amount was measured. Sensitization to extracellular vesicles in dust was defined as positive when more than 95% of vesicle-specific IgG antibody values present in normal samples.

그 결과, 도 6에 나타낸 바와 같이, 정상인인 경우 4.4%, 천식환자인 경우 13.6%, 만성폐쇄성폐질환 환자인 경우 29.3%, 폐암환자인 경우 54.9%에서 감작되어 있었다.As a result, as shown in Fig. 6, 4.4% in normal people, 13.6% in asthma patients, 29.3% in patients with chronic obstructive pulmonary disease, 54.9% in lung cancer patients.

실시예Example 5. 실내 먼지 내  5. indoor dust 세포밖Extracellular 소포체에 대한  For endoplasmic reticulum 감작과Sensitization 천식,  asthma, 만성폐쇄성폐질환Chronic Obstructive Pulmonary Disease , 폐암의 연관성 분석Association of lung cancer

실내 먼지내 세균 유래 세포밖 소포체에 대한 감작과 천식, 만성폐쇄성폐질환, 폐암과의 연관성을 multiple logistic regression analysis로 분석하였다. 흡연 혹은 실내 먼지 내 세포밖 소포체에의 감작과 천식과의 연관성을 평가한 결과, 하기 표 2에 나타낸 바와 같이, 실내 먼지내 세포밖 소포체에 감작된 경우 천식의 발생 위험은 감작되지 않은 사람에 비하여 3.3배 증가한 반면, 흡연을 하는 경우에는 비흡연자에 비하여 천식 발생이 오히려 감소하였다.Multiple logistic regression analysis was performed to investigate the sensitization of bacteria-derived extracellular vesicles in indoor dust and their association with asthma, chronic obstructive pulmonary disease and lung cancer. As a result of evaluating the association between sensitization to extracellular vesicles in smoking or indoor dust and asthma, as shown in Table 2 below, the risk of asthma is increased when sensitized to extracellular vesicles in indoor dust compared to non-sensitized persons. On the other hand, smoking increased by 3.3 times compared to nonsmokers, resulting in a decrease in asthma.

Univariable analysisUnivariable analysis Multivariable analysisMultivariable analysis odds ratioodds ratio 95% confidence interval95% confidence interval p- value†p- value † odds ratioodds ratio 95% confidence interval95% confidence interval p- value†p- value † AgingAging 1.021.02 1.00-1.041.00-1.04 0.0230.023 1.031.03 1.01-1.051.01-1.05 0.0020.002 Female genderFemale gender 1.81.8 1.12-2.921.12-2.92 0.0150.015 0.70.7 0.3-1.50.3-1.5 0.3520.352 Cigarette smokingCigarette smoking 0.40.4 0.2-0.60.2-0.6 <0.001<0.001 0.30.3 0.1-0.60.1-0.6 0.0010.001 Anti-dust EV IgG (+)*Anti-dust EV IgG (+) * 3.43.4 1.2-9.71.2-9.7 0.0240.024 3.33.3 1.1-10.01.1-10.0 0.0390.039

*High serum IgG against dust EVs (extracellular vesicles)High serum IgG against dust EVs (extracellular vesicles)

†Linear logistic regression analysis vs. control subjects† Linear logistic regression analysis vs. control subjects

또한, 흡연 혹은 실내 먼지 내 소포체에의 감작과 만성폐쇄성폐질환과의 연관성을 분석하였을 때, 하기 표 3에 나타낸 바와 같이, 먼지 내 세포밖 소포체에 감작된 경우에 질환의 발생이 감작되지 않은 사람에 비하여 8.0배 증가하였고, 흡연을 하는 경우에도 비흡연자에 비하여 3.7배 증가하였다.In addition, when analyzing the association between sensitization to the endoplasmic reticulum in smoking or indoor dust and chronic obstructive pulmonary disease, as shown in Table 3 below, people who are not sensitized to the occurrence of disease when sensitized to extracellular vesicles in the dust It was 8.0 times higher than that of non-smokers and 3.7 times higher than non-smokers.

Univariable analysisUnivariable analysis Multivariable analysisMultivariable analysis odds ratioodds ratio 95% confidence interval95% confidence interval p- value†p- value † odds ratioodds ratio 95% confidence interval95% confidence interval p- value†p- value † AgingAging 1.21.2 1.2-1.31.2-1.3 <0.001<0.001 1.21.2 1.1-1.21.1-1.2 <0.001<0.001 Female genderFemale gender 0.20.2 0.1-0.30.1-0.3 <0.001<0.001 1.01.0 0.3-2.80.3-2.8 0.930.93 Cigarette smokingCigarette smoking 5.55.5 3.2-9.53.2-9.5 <0.001<0.001 3.73.7 1.4-10.11.4-10.1 0.010.01 Anti-dust EV IgG (+)*Anti-dust EV IgG (+) * 8.98.9 3.2-25.33.2-25.3 <0.001<0.001 8.08.0 2.0-32.52.0-32.5 0.0030.003

*High serum IgG against dust EVs (extracellular vesicles)High serum IgG against dust EVs (extracellular vesicles)

†Linear logistic regression analysis vs. control subjects† Linear logistic regression analysis vs. control subjects

또한, 흡연 혹은 실내 먼지 내 소포체에의 감작과 폐암 발생과의 연관성을 평가하였을 때, 하기 표 4에 나타낸 바와 같이, 먼지 내 세포밖 소포체에 감작된 경우 폐암 발생의 위험이 감작되지 않은 사람에 비하여 38.7배 증가하였고, 흡연을 하는 경우에 비흡연자에 비하여 2.7배 증가하였다.In addition, when evaluating the association between the sensitization of the endoplasmic reticulum in smoking or indoor dust and the occurrence of lung cancer, as shown in Table 4 below, when the extracellular vesicles in the dust are sensitized, compared with a person who is not at risk of developing lung cancer. It was 38.7 times higher and 2.7 times higher than the non-smoker.

Univariable analysisUnivariable analysis Multivariable analysisMultivariable analysis odds ratioodds ratio 95% confidence interval95% confidence interval p- value†p- value † odds ratioodds ratio 95% confidence interval95% confidence interval p- value†p- value † AgingAging 1.21.2 1.1-1.21.1-1.2 <0.001<0.001 1.21.2 1.1-1.21.1-1.2 <0.001<0.001 Female genderFemale gender 0.20.2 0.1-0.40.1-0.4 <0.001<0.001 0.70.7 0.3-1.80.3-1.8 0.450.45 Cigarette smokingCigarette smoking 3.13.1 1.9-5.01.9-5.0 <0.001<0.001 2.72.7 1.1-7.01.1-7.0 0.030.03 Anti-dust EV IgG (+)*Anti-dust EV IgG (+) * 26.026.0 9.3-72.69.3-72.6 <0.001<0.001 38.738.7 10.4-144.310.4-144.3 <0.001<0.001

*High serum IgG against dust EVs (extracellular vesicles)High serum IgG against dust EVs (extracellular vesicles)

†Linear logistic regression analysis vs. control subjects† Linear logistic regression analysis vs. control subjects

실시예Example 6. 천식,  6. Asthma, 만성폐쇄성폐질환Chronic Obstructive Pulmonary Disease , 폐암 환자 샘플에서 In lung cancer patient samples StaphylococcusStaphylococcus , , AcinetobacterAcinetobacter , , PseudomonasPseudomonas , , EnterobacterEnterobacter 속 세균 유래  Bacterial origin 세포밖Extracellular 소포체 특이  Endoplasmic reticulum IgGIgG , IgG1, , IgG1, IgG4IgG4 항체 측정 Antibody measurement

6-1. 각 세균 유래 6-1. Each bacterium originated 세포밖Extracellular 소포체 분리 및  Endoplasmic reticulum separation and 세포밖Extracellular 소포체 특이  Endoplasmic reticulum IgGIgG , , IgG1IgG1 , IgG4 항체 측정, IgG4 antibody measurement

실시예 3의 메타게놈분석 결과에서 실내 먼지 내 포도상구균(Staphylococcus), 아시네토박터(Acinetobacter), 슈도모나스(Pseudomonas), 엔테로박터(Enterobacter) 속 세균 유래 세포밖 소포체가 다량 존재한다는 연구결과를 토대로 하여, 상기 실시예 4에서 기술한 4가지 그룹, 즉, 천식, 만성폐쇄성폐질환, 폐암, 및 정상인의 혈액 및 객담에서 상기 세균에서 유래하는 세포밖 소포체에 대한 특이 IgG, IgG1, IgG4 항체를 측정하였다.Example 3 within the Staphylococcus aureus of the meta-house dust in genome analysis (Staphylococcus), and based on the findings that the Acinetobacter (Acinetobacter), Pseudomonas (Pseudomonas), Enterobacter (Enterobacter) in germ cells derived from outside the endoplasmic reticulum are large amounts present Specific IgG, IgG1, IgG4 antibodies against extracellular vesicles derived from the bacteria were measured in the four groups described in Example 4, namely, asthma, chronic obstructive pulmonary disease, lung cancer, and blood and sputum of normal persons. .

각 속에 해당하는 세균 즉, 황색포도상구균(Staphylococcus aureus), 아시네토박터 바우마니(Acinetobacter baumannii), 녹농균(Pseudomonas aeruginosa), 및 엔테로박터 에어로게네스(Enterobacter aerogenes)를 액체 영양배지에 접종하고 교반/항온 배양기 내 37℃ 하에서 흡광도 1.5가 될 때까지 배양하였다. 이후 고속원심분리기를 이용하여 4℃, 10,000 x g에서 20분 동안 원심분리를 수행하여 세균 및 상층액으로 분리하고, 상층액 부분만을 취하여 0.45 μm인 멤브레인 필터(membrane filter)에 1회 통과시켰다. 다음으로 고속원심분리를 위한 농축을 위해 농축기(quickstand, GE healthcare)로 상층액을 300 ㎖까지 농축 후, 다시 0.22 μm인 멤브레인 필터(membrane filter)에 1회 통과시켰다. 이를 초고속원심분리용 튜브(45 Ti, 70 ㎖, Beckman coulter)에 나눠 담고 4℃, 100,000 x g에서 3시간 동안 초고속 원심분리를 수행하였으며, 상층액 부분은 버리고 튜브 하단의 침전물을 PBS로 현탁하여 세포밖 소포체를 분리하였다.Bacteria corresponding to each genus, Staphylococcus aureus , Acinetobacter baumannii ), Pseudomonas aeruginosa ), and enterobacter aerogenes ( Enterobacter aerogenes ) were inoculated in a liquid nutrient medium and incubated at 37 ° C. under agitation / constant incubator until the absorbance was 1.5. Thereafter, centrifugation was performed at 4 ° C. at 10,000 × g for 20 minutes using a high-speed centrifuge to separate bacteria and supernatant, and only the supernatant was removed and passed once through a 0.45 μm membrane filter. Next, the supernatant was concentrated to 300 ml with a quickstand (GE healthcare) for concentration for high-speed centrifugation, and then passed once through a membrane filter (0.22 μm). This was divided into ultra high-speed centrifuge tubes (45 Ti, 70 ml, Beckman coulter), and ultra-high centrifugation was performed at 4 ° C. and 100,000 x g for 3 hours. Outer endoplasmic reticulum was isolated.

환자 샘플내 세포밖 소포체 특이 항체 즉, IgG, IgG1, IgG4의 양을 측정하기 위해 상기 세균들에서 분리한 세포밖 소포체 50 ng을 96-well plate의 각 well에 하루 동안 안착시켰다. 세포밖 소포체 특이 IgG, IgG1, IgG4 정량을 위해 각각 anti-human IgG 항체, anti-human IgG1 항체, anti-human IgG4 항체를 세포밖 소포체 대신 안착하였다. 다음날, 5% 탈지분유로 항체 및 세포밖 소포체 안착 간극을 메우고, 확보한 샘플을 5% 탈지분유에 1000배 희석하여 반응시켰다. 다음으로 홀스레디쉬 페록시다아제가 접합된 각 2차 항체(Horseradish peroxidase-conjugated anti-IgG, anti-IgG1, anti-IgG4)(abcam, Cambridge, UK)를 5% 탈지분유액에 희석하여 반응시킨 후, microplate reader를 통해 각 IgG 항체의 양을 측정하였다. 각각의 세균 유래 세포밖 소포체에의 감작은 정상인의 혈액 및 객담에 존재하는 소포체 특이 IgG, IgG1, IgG4 항체 값의 95% 이상을 보이는 경우에 양성으로 정의하였다.To measure the amount of extracellular vesicle specific antibodies, ie IgG, IgG1, IgG4, in patient samples, 50 ng of extracellular vesicles isolated from these bacteria were placed in each well of a 96-well plate for one day. Anti-human IgG antibodies, anti-human IgG1 antibodies, and anti-human IgG4 antibodies were deposited instead of the extracellular vesicles for the quantification of extracellular vesicle-specific IgG, IgG1, and IgG4, respectively. The next day, 5% skim milk powder filled the antibody and extracellular vesicle seating gap, and the obtained sample was reacted by diluting 1000-fold in 5% skim milk powder. Next, each secondary antibody (Horseradish peroxidase-conjugated anti-IgG, anti-IgG1, anti-IgG4) (abcam, Cambridge, UK) conjugated with horseradish peroxidase was diluted and reacted with 5% skim milk powder. Then, the amount of each IgG antibody was measured through a microplate reader. Sensitization to each bacterial-derived extracellular vesicles was defined as positive when showing at least 95% of the vesicle-specific IgG, IgG1, IgG4 antibody values present in normal human blood and sputum.

6-2. 황색포도상구균(6-2. Staphylococcus aureus ( Staphylococcus Staphylococcus aureusaureus ) 유래 Origin 세포밖Extracellular 소포체  Endoplasmic reticulum 감작과Sensitization 천식,  asthma, 만성폐쇄성폐질환Chronic Obstructive Pulmonary Disease , 폐암의 연관성 분석 Association of lung cancer

황색포도상구균 유래 세포밖 소포체 감작과 천식, 만성폐쇄성폐질환, 폐암과의 연관성을 multiple logistic regression analysis로 분석하였다. Multiple logistic regression analysis was performed to determine the association between Staphylococcus aureus-derived extracellular vesicle sensitization, asthma, chronic obstructive pulmonary disease, and lung cancer.

그 결과, 하기 표 5에 나타낸 바와 같이, 황색포도상구균 유래 세포밖 소포체에의 감작과 천식과의 연관성을 평가한 경우, 소포체에 감작된 경우 천식의 발생 위험은 감작되지 않은 사람에 비하여 3.0배 증가하였다. 황색포도상구균 유래 세포밖 소포체에의 감작과 만성폐쇄성폐질환의 연관성을 분석한 결과, 소포체에 감작된 경우 감작되지 않은 사람에 비하여 12.6배 발생률이 증가하였다. 또한, 황색포도상구균 유래 세포밖 소포체에의 감작과 폐암과의 연관성을 분석한 결과, 소포체에 감작된 경우 감작되지 않은 경우에 비하여 폐암 발생률이 11.2배 증가하는 것으로 나타났다.As a result, as shown in Table 5 below, in assessing the association between sensitization to Staphylococcus aureus-derived extracellular vesicles and asthma, the risk of asthma is 3.0-fold higher than that of non-sensitized individuals. It was. Analysis of the association between sensitization to Staphylococcus aureus-derived extracellular vesicles and chronic obstructive pulmonary disease showed a 12.6-fold increase in the incidence of vesicle sensitization compared to non-sensitized individuals. In addition, analysis of the association between sensitization to extracellular vesicles derived from Staphylococcus aureus and lung cancer showed a 11.2-fold increase in lung cancer incidence compared with sensitized ER.

AsthmaAsthma COPDCOPD Lung cancerLung cancer odds ratio (95% CI)odds ratio (95% CI) p- value†p- value † odds ratio (95% CI)odds ratio (95% CI) p- value†p- value † odds ratio (95% CI)odds ratio (95% CI) p- value†p- value † AgingAging 1.0 (1.0-1.0)1.0 (1.0-1.0) 0.0030.003 1.2 (1.1-1.3)1.2 (1.1-1.3) <0.001<0.001 1.2 (1.1-1.2)1.2 (1.1-1.2) <0.001<0.001 Female genderFemale gender 0.8 (0.4-1.6)0.8 (0.4-1.6) 0.4970.497 0.9 (0.3-2.8)0.9 (0.3-2.8) 0.900.90 0.5 (0.2-1.2)0.5 (0.2-1.2) 0.110.11 Cigarette smokingCigarette smoking 0.3 (0.2-0.7)0.3 (0.2-0.7) 0.0050.005 5.6 (2.0-15.8)5.6 (2.0-15.8) 0.0010.001 2.0 (0.9-4.5)2.0 (0.9-4.5) 0.110.11 Anti-staphylococcal EV IgG (+)*Anti-staphylococcal EV IgG (+) * 3.0 (1.0-8.9)3.0 (1.0-8.9) 0.0480.048 12.6 (2.7-59.4)12.6 (2.7-59.4) 0.0010.001 11.2 (3.1-40.2)11.2 (3.1-40.2) <0.001<0.001

*High serum IgG against dust EVs (extracellular vesicles)High serum IgG against dust EVs (extracellular vesicles)

†Linear logistic regression analysis vs. control subjects† Linear logistic regression analysis vs. control subjects

6-3. 6-3. 아시네토박터Acinetobacter 바우마니Baumani (( AcinetobacterAcinetobacter baumanniibaumannii ) 유래 Origin 세포밖Extracellular 소포체 감작과 천식,  Endoplasmic reticulum and asthma, 만성폐쇄성폐질환Chronic Obstructive Pulmonary Disease , 폐암의 연관성 분석 Association of lung cancer

아시네토박터 바우마니균 유래 세포밖 소포체 감작과 천식, 만성폐쇄성폐질환, 폐암과의 연관성을 multiple logistic regression analysis로 분석하였다. Multiple logistic regression analysis was performed to determine the association between extracellular vesicle sensitization and asthma, chronic obstructive pulmonary disease, and lung cancer derived from Acinetobacter Baumani.

그 결과, 하기 표 6에 나타낸 바와 같이, 아시네토박터 바우마니균 유래 세포밖 소포체에의 감작과 천식과의 연관성을 평가한 결과, 소포체에 감작된 경우 천식의 발생 위험은 감작되지 않은 사람에 비하여 2.2배 증가하였다. 아시네토박터균 바우마니균 유래 세포밖 소포체에의 감작과 만성폐쇄성폐질환의 연관성을 분석한 결과, 소포체에 감작된 경우 감작되지 않은 사람에 비하여 6.3배 발생률이 증가하였다. 또한, 아시네토박터 바우마니균 유래 세포밖 소포체에의 감작과 폐암과의 연관성을 분석한 결과, 소포체에 감작된 경우 감작되지 않은 경우에 비하여 폐암 발생률이 8.0배 증가하는 것으로 나타났다.As a result, as shown in Table 6 below, associating sensitization to acetobacter Baumani bacteria-derived extracellular vesicles and asthma, the risk of developing asthma when sensitized to endoplasmic reticulum, compared to those who are not sensitized It increased 2.2 times. The analysis of the association between sensitization to the extracellular vesicles derived from the Acinetobacter bacterium Baumani and the presence of chronic obstructive pulmonary disease showed a 6.3-fold increase in the incidence of non-sensitized individuals. In addition, analysis of the association between sensitization to extracellular vesicles derived from Acinetobacter Baumani and lung cancer showed a 8.0-fold increase in lung cancer incidence compared to sensitization to vesicles.

AsthmaAsthma COPDCOPD Lung cancerLung cancer odds ratio (95% CI)odds ratio (95% CI) p- value†p- value † odds ratio (95% CI)odds ratio (95% CI) p- value†p- value † odds ratio (95% CI)odds ratio (95% CI) p- value†p- value † AgingAging 1.0 (1.0-1.0)1.0 (1.0-1.0) 0.0040.004 1.2 (1.1-1.2)1.2 (1.1-1.2) <0.001<0.001 1.1 (1.1-1.2)1.1 (1.1-1.2) <0.001<0.001 Female genderFemale gender 0.7 (0.3-1.5)0.7 (0.3-1.5) 0.3750.375 0.7 (0.2-2.1)0.7 (0.2-2.1) 0.5410.541 0.5 (0.2-1.2)0.5 (0.2-1.2) 0.0990.099 Cigarette smokingCigarette smoking 0.3 (0.1-0.6)0.3 (0.1-0.6) 0.0010.001 3.3 (1.2-9.2)3.3 (1.2-9.2) 0.0210.021 2.0 (0.9-4.6)2.0 (0.9-4.6) 0.1080.108 Anti-Acinetobacter EV IgG (+)*Anti-Acinetobacter EV IgG (+) * 2.2 (0.7-6.7)2.2 (0.7-6.7) 0.1580.158 6.3 (1.5-26.7)6.3 (1.5-26.7) 0.0130.013 8.0 (2.1-30.2)8.0 (2.1-30.2) 0.0020.002

*High serum IgG against Acinetobacter EVs (extracellular vesicles)High serum IgG against Acinetobacter EVs (extracellular vesicles)

†Linear logistic regression analysis vs. control subjects† Linear logistic regression analysis vs. control subjects

6-4. 녹농균(6-4. Pseudomonas aeruginosa ( PseudomonasPseudomonas aeruginosaaeruginosa ) 유래 Origin 세포밖Extracellular 소포체  Endoplasmic reticulum 감작과Sensitization 천식,  asthma, 만성폐쇄성폐질환Chronic Obstructive Pulmonary Disease , 폐암의 연관성 분석 Association of lung cancer

녹농균 유래 세포밖 소포체 감작과 천식, 만성폐쇄성폐질환, 폐암과의 연관성을 multiple logistic regression analysis로 분석하였다. Multiple logistic regression analysis was performed to determine the association between Pseudomonas aeruginosa-derived extracellular vesicle sensitization, asthma, chronic obstructive pulmonary disease and lung cancer.

그 결과, 하기 표 7에 나타낸 바와 같이, 녹농균 유래 세포밖 소포체에의 감작과 천식과의 연관성을 평가한 결과, 소포체에 감작된 경우 천식의 발생 위험은 감작되지 않은 사람에 비하여 6.2배 증가하였다. 녹농균 유래 세포밖 소포체에의 감작과 만성폐쇄성폐질환의 연관성을 분석한 결과, 소포체에 감작된 경우 감작되지 않은 사람에 비하여 4.5배 발생률이 증가하였다. 또한, 녹농균 유래 세포밖 소포체에의 감작과 폐암과의 연관성을 분석한 결과, 소포체에 감작된 경우 감작되지 않은 경우에 비하여 폐암 발생률이 17.5배 증가하는 것으로 나타났다.As a result, as shown in Table 7 below, the association between sensitization to Pseudomonas aeruginosa-derived extracellular vesicles and asthma was evaluated. When sensitized to endoplasmic reticulum, the risk of asthma was 6.2 times higher than that of non-sensitized persons. The analysis of the association between sensitization to Pseudomonas aeruginosa-derived extracellular vesicles and chronic obstructive pulmonary disease showed a 4.5-fold increase in the incidence of endoplasmic reticulum. In addition, the analysis of the association between sensitization to Pseudomonas aeruginosa-derived extracellular vesicles and lung cancer showed a 17.5-fold increase in lung cancer incidence when sensitized to endoplasmic reticulum.

AsthmaAsthma COPDCOPD Lung cancerLung cancer odds ratio (95% CI)odds ratio (95% CI) p- value†p- value † odds ratio (95% CI)odds ratio (95% CI) p- value†p- value † odds ratio (95% CI)odds ratio (95% CI) p- value†p- value † AgingAging 1.0 (1.0-1.1)1.0 (1.0-1.1) 0.0030.003 1.2 (1.1-1.2)1.2 (1.1-1.2) <0.001<0.001 1.2 (1.1-1.2)1.2 (1.1-1.2) <0.001<0.001 Female genderFemale gender 0.8 (0.4-1.7)0.8 (0.4-1.7) 0.5940.594 1.0 (0.3-3.0)1.0 (0.3-3.0) 0.9970.997 0.5 (0.2-1.3)0.5 (0.2-1.3) 0.1680.168 Cigarette smokingCigarette smoking 0.3 (0.2-0.7)0.3 (0.2-0.7) 0.0050.005 4.3 (1.6-11.8)4.3 (1.6-11.8) 0.0050.005 2.0 (0.8-4.7)2.0 (0.8-4.7) 0.1330.133 Anti-Pseudomonas EV IgG (+)*Anti-Pseudomonas EV IgG (+) * 6.2 (2.1-18.0)6.2 (2.1-18.0) 0.0010.001 4.5 (1.2-16.6)4.5 (1.2-16.6) 0.0240.024 17.5 (4.7-64.5)17.5 (4.7-64.5) <0.001<0.001

*High serum IgG against Pseudomonas EVs (extracellular vesicles)High serum IgG against Pseudomonas EVs (extracellular vesicles)

†Linear logistic regression analysis vs. control subjects† Linear logistic regression analysis vs. control subjects

6-5. 엔테로박터 6-5. Enterobacter 에어로게네스Aerogenes (( EnterobacterEnterobacter aerogenesaerogenes ) 유래 Origin 세포밖Extracellular 소포체 감작과 천식,  Endoplasmic reticulum and asthma, 만성폐쇄성폐질환Chronic Obstructive Pulmonary Disease , 폐암의 연관성 분석 Association of lung cancer

엔테로박터 에어로게네스균 유래 세포밖 소포체 감작과 천식, 만성폐쇄성폐질환, 폐암과의 연관성을 multiple logistic regression analysis로 분석하였다. Multiple logistic regression analysis was performed to determine the association between Enterobacter aerogenes-derived extracellular vesicle sensitization and asthma, chronic obstructive pulmonary disease, and lung cancer.

그 결과, 하기 표 8에 나타낸 바와 같이, 엔테로박터 에어로게네스균 유래 세포밖 소포체에의 감작과 천식과의 연관성을 평가한 결과, 소포체에 감작된 경우 천식의 발생 위험은 감작되지 않은 사람에 비하여 2.4배 증가하였다. 엔테로박터 에어로게네스균 유래 세포밖 소포체에의 감작과 만성폐쇄성폐질환의 연관성을 분석한 결과, 소포체에 감작된 경우 감작되지 않은 사람에 비하여 2.8배 발생률이 증가하였다. 또한, 엔테로박터 에어로게네스균 유래 세포밖 소포체에의 감작과 폐암과의 연관성을 분석한 결과, 소포체에 감작된 경우 감작되지 않은 경우에 비하여 폐암 발생률이 8.3배 증가하는 것으로 나타났다.As a result, as shown in Table 8 below, as a result of evaluating the association between Enterobacter aerogenes-derived extracellular vesicles and asthma, the risk of developing asthma when sensitized to the endoplasmic reticulum is compared to those who are not sensitized. 2.4-fold increase. Analysis of the association between Enterobacter aerogenes-derived extracellular vesicles and chronic obstructive pulmonary disease showed a 2.8-fold increase in the incidence of endoplasmic reticulum. In addition, as a result of analyzing the association between Enterobacter aerogenes-derived extracellular vesicles and lung cancer, lung sensitization was 8.3 times higher than the sensitized endoplasmic reticulum.

AsthmaAsthma COPDCOPD Lung cancerLung cancer odds ratio (95% CI)odds ratio (95% CI) p- value†p- value † odds ratio (95% CI)odds ratio (95% CI) p- value†p- value † odds ratio (95% CI)odds ratio (95% CI) p- value†p- value † AgingAging 1.0 (1.0-1.0)1.0 (1.0-1.0) 0.0050.005 1.2 (1.1-1.2)1.2 (1.1-1.2) <0.001<0.001 1.2 (1.1-1.2)1.2 (1.1-1.2) <0.001<0.001 Female genderFemale gender 0.8 (0.4-1.7)0.8 (0.4-1.7) 0.5640.564 1.0 (0.3-3.1)1.0 (0.3-3.1) 0.9540.954 0.6 (0.3-1.6)0.6 (0.3-1.6) 0.3580.358 Cigarette smokingCigarette smoking 0.3 (0.1-0.7)0.3 (0.1-0.7) 0.0040.004 4.6 (1.7-12.7)4.6 (1.7-12.7) 0.0030.003 2.3 (1.0-5.4)2.3 (1.0-5.4) 0.0580.058 Anti-Enterovacter EV IgG (+)*Anti-Enterovacter EV IgG (+) * 2.4 (0.8-7.2)2.4 (0.8-7.2) 0.1220.122 2.8 (0.8-10.1)2.8 (0.8-10.1) 0.1120.112 8.3 (2.3-30.0)8.3 (2.3-30.0) 0.0010.001

*High serum IgG against Enterovacter EVs (extracellular vesicles)High serum IgG against Enterovacter EVs (extracellular vesicles)

†Linear logistic regression analysis vs. control subjects† Linear logistic regression analysis vs. control subjects

실시예Example 7. 상기 네 가지 세균 유래  7. Origin of the above four bacteria 세포밖Extracellular 소포체에  On the endoplasmic reticulum 감작Sensitization 개수와 천식,  Asthma, 만성Chronic 폐쇄성폐질환, 폐암의 연관성 분석 Association between obstructive pulmonary disease and lung cancer

실시예 6의 4가지 세균 즉, 황색포도상구균(Staphylococcus aureus), 아시네토박터 바우마니(Acinetobacter baumannii), 녹농균(Pseudomonas aeruginosa), 엔테로박터 에어로게네스(Enterobacter aerogenes) 유래 세포밖 소포체에 대해 질환별 감작개수와 연관성을 확인해보고자 하였다.Four bacteria of Example 6, namely Staphylococcus aureus , Acinetobacter Baumani ( Acinetobacter) baumannii ), Pseudomonas aeruginosa ), Enterobacter The purpose of this study was to determine the relationship between the number of aerogenes ) -derived extracellular vesicles and their sensitivity to disease.

그 결과, 도 7에 나타낸 바와 같이, IgG 항체를 측정하였을 때 상기 네 가지 세균유래 세포밖 소포체 중에서 3가지 이상의 세균 유래 소포체에 IgG 항체가 증가된 경우는 정상인에는 없었고, 천식, 만성폐쇄성폐질환, 그리고 폐암환자에서만 관찰되었다. 상기 4가지 세균 유래 소포체 모두에 IgG1 항체가 증가된 경우에는 도 8에 나타낸 바와 같이, 정상인과 천식환자에선 관찰되지 않았고, 만성폐쇄성폐질환과 폐암환자에서만 관찰되었다. 또한, 상기 4가지 세균 유래 소포체 중에서 2가지 혹은 3가지의 소포체에 특이 IgG4가 증가된 경우는 폐암환자에서 두드러지게 관찰됨을 도 9에 나타내었다.As a result, as shown in FIG. 7, when IgG antibody was measured, there was no increase in IgG antibody in three or more bacterial-derived vesicles among the four bacterial-derived extracellular vesicles, but asthma, chronic obstructive lung disease, And only in lung cancer patients. When IgG1 antibody was increased in all four bacterial-derived endoplasmic reticulum, as shown in FIG. 8, it was not observed in normal and asthmatic patients, but only in patients with chronic obstructive pulmonary disease and lung cancer. In addition, it is shown in Fig. 9 that the specific IgG4 increased in two or three endoplasmic reticulum among the four bacterial-derived endoplasmic reticulum was observed in lung cancer patients.

상기 진술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. The description of the present invention set forth above is for illustrative purposes, and one of ordinary skill in the art may understand that the present invention may be easily modified into other specific forms without changing the technical spirit or essential features of the present invention. There will be. Therefore, it should be understood that the embodiments described above are exemplary in all respects and not restrictive.

Claims (8)

하기의 단계를 포함하는, 호흡기 염증성 질환의 진단방법:A method for diagnosing a respiratory inflammatory disease, comprising the following steps: (A) 환자샘플을 실내먼지 세균 유래의 세포밖 소포체 또는 이 소포체 유래 단백질과 반응시키는 단계; (A) reacting a patient sample with extracellular vesicles or proteins derived from indoor dust bacteria; (B) 상기 반응물에 항-인간 IgG 항체를 반응시켜 샘플내 IgG 항체의 양을 측정하는 단계; 및(B) reacting the reactant with an anti-human IgG antibody to determine the amount of IgG antibody in the sample; And (C) 상기 샘플내 IgG 항체의 양이 정상인에 비하여 2배 이상 증가되어 있을 경우 호흡기 염증성 질환으로 판정하는 단계.(C) determining the respiratory inflammatory disease when the amount of IgG antibody in the sample is more than doubled compared to the normal person. 제 1 항에 있어서, The method of claim 1, 상기 세포밖 소포체 및 단백질은 포도상구균(Staphylococcus), 아시네토박터(Acinetobacter), 슈도모나스(Pseudomonas) 및 엔테로박터(Enterobacter)로 이루어진 군에서 선택되는 1종 이상의 균에서 유래되는 것임을 특징으로 하는, 진단방법.Diagnostic method The extracellular vesicles, and proteins, characterized in staphylococci (Staphylococcus), Acinetobacter (Acinetobacter), Pseudomonas (Pseudomonas) and Enterobacter that is (Enterobacter) derived from one strain or more kinds selected from the group consisting of, . 제 2 항에 있어서, The method of claim 2, 상기 포도상구균은 황색포도상구균(Staphylococcus aureus)이고, 상기 아시네토박터는 아시네토박터 바우마니(Acinetobacter baumannii)이고, 상기 슈도모나스는 녹농균(Pseudomonas aeruginosa)이고, 상기 엔테로박터는 엔테로박터 에어로게네스(Enterobacter aerogenes)인 것을 특징으로 하는, 진단방법.The Staphylococcus aureus is Staphylococcus aureus , and the Acinetobacter is Acinetobacter. baumannii ), and the pseudomonas is Pseudomonas aeruginosa), and the Enterobacter diagnostic method, characterized in that the Enterobacter aero to Ness (Enterobacter aerogenes). 제 1 항에 있어서, The method of claim 1, 상기 환자샘플은 혈액 및 객담으로 이루어진 군에서 선택되는 것을 특징으로 하는, 진단방법.The patient sample is characterized in that selected from the group consisting of blood and sputum, diagnostic method. 제 1 항에 있어서, The method of claim 1, 상기 IgG 항체는 IgG1 또는 IgG4인 것을 특징으로 하는, 진단방법.The IgG antibody is characterized in that the IgG1 or IgG4, diagnostic method. 제 1 항에 있어서, The method of claim 1, 상기 세포밖 소포체는 평균 직경이 10-300 nm인 것을 특징으로 하는, 진단방법.The extracellular vesicles are characterized in that the average diameter of 10-300 nm, diagnostic methods. 제 1 항에 있어서, The method of claim 1, 상기 호흡기 염증성 질환은 천식, 만성폐쇄성폐질환, 및 폐암으로 이루어진 군에서 선택되는 것을 특징으로 하는, 진단방법.The respiratory inflammatory disease is characterized in that selected from the group consisting of asthma, chronic obstructive pulmonary disease, lung cancer. 실내먼지 세균 유래 세포밖 소포체의 호흡기 염증성 질환 진단용도.For the diagnosis of respiratory inflammatory diseases of extracellular vesicles derived from indoor dust bacteria.
PCT/KR2016/001502 2015-02-17 2016-02-15 Method for diagnosing inflammatory respiratory diseases using outer membrane vesicles derived from bacteria Ceased WO2016133324A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2015-0024249 2015-02-17
KR1020150024249A KR20160101521A (en) 2015-02-17 2015-02-17 Method for diagnosing of respiratory inflammatory diseases using bacteria-derived extracellular vesicles

Publications (1)

Publication Number Publication Date
WO2016133324A1 true WO2016133324A1 (en) 2016-08-25

Family

ID=56692369

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/001502 Ceased WO2016133324A1 (en) 2015-02-17 2016-02-15 Method for diagnosing inflammatory respiratory diseases using outer membrane vesicles derived from bacteria

Country Status (2)

Country Link
KR (1) KR20160101521A (en)
WO (1) WO2016133324A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019139360A1 (en) * 2018-01-12 2019-07-18 주식회사 엠디헬스케어 Nanovesicles derived from faecalibacterium prausnitzii, and uses thereof
WO2019139279A1 (en) * 2018-01-12 2019-07-18 주식회사 엠디헬스케어 Nanovesicles derived from morganella bacteria, and uses thereof
EP3561069A4 (en) * 2016-12-26 2020-08-19 MD Healthcare Inc. METHOD OF DIAGNOSIS OF LUNG CANCER BY BACTERIAL METAGENOME ANALYSIS
US10858670B2 (en) 2018-01-12 2020-12-08 Md Healthcare Inc. Nano-vesicles derived from genus Morganella bacteria and use thereof
EP3587596A4 (en) * 2017-02-24 2020-12-16 MD Healthcare Inc. METHOD OF DIAGNOSIS OF CHRONIC OBSTRUCTIVE RESPIRATORY DISEASE BY BACTERIAL METAGENOMANALYSIS
US11666607B2 (en) 2018-01-12 2023-06-06 Md Healthcare Inc. Nanovesicles derived from Faecalibacterium prausnitzii and uses thereof

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019074216A1 (en) * 2017-10-13 2019-04-18 주식회사 엠디헬스케어 Method for diagnosing alzheimer dementia via bacterial metagenomic analysis
WO2019168331A1 (en) * 2018-02-28 2019-09-06 주식회사 엠디헬스케어 Nanovesicles derived from pseudomonas bacteria and use thereof
WO2019168329A1 (en) * 2018-02-28 2019-09-06 주식회사 엠디헬스케어 Nanovesicles derived from acinetobacter bacteria and use thereof
EP4030168A4 (en) * 2019-09-10 2023-06-14 MD Healthcare Inc. Lung disease diagnostic method based on antibodies against microorganism-derived vesicles
KR102299252B1 (en) * 2019-09-10 2021-09-08 주식회사 엠디헬스케어 Method for diagnosis of lung disease based on antibodies for microbial-derived vesicles
KR102482695B1 (en) * 2020-12-04 2023-01-02 주식회사 엠디헬스케어 Methods for diagnosing of Chronic urticaria
KR102652313B1 (en) * 2021-03-05 2024-03-29 재단법인 아산사회복지재단 Method for analysis of bacteria metagenome using exhaled condensate sample
KR102631074B1 (en) * 2021-04-09 2024-01-30 연세대학교 산학협력단 Novel Indolizine Derivatives and A Composition for Treating or Preventing Fibrosis Comprising the Same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035733A2 (en) * 2003-10-09 2005-04-21 Health Protection Agency Modified whole cell, cell extract and omv-based vaccines
KR20110038575A (en) * 2009-10-08 2011-04-14 주식회사이언메딕스 Compositions comprising indoor air-derived extracellular vesicles and uses thereof
KR20120114872A (en) * 2011-04-08 2012-10-17 주식회사이언메딕스 Extracellular vesicles derived from genus acinetobacter and use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035733A2 (en) * 2003-10-09 2005-04-21 Health Protection Agency Modified whole cell, cell extract and omv-based vaccines
KR20110038575A (en) * 2009-10-08 2011-04-14 주식회사이언메딕스 Compositions comprising indoor air-derived extracellular vesicles and uses thereof
KR20120114872A (en) * 2011-04-08 2012-10-17 주식회사이언메딕스 Extracellular vesicles derived from genus acinetobacter and use thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KIM, Y. -S ET AL.: "Extracellular Vesicles, Especially derived from Gram-Negative Bacteria, in Indoor Dust Induce Neutrophilic Pulmonary Inflammation Associated with both Th1 and Th17 Cell Responses", CLINICAL EXPERIMENTAL ALLERGY, vol. 43, no. 4, April 2013 (2013-04-01), pages 443 - 454, XP055067568, DOI: doi:10.1111/cea.12085 *
LEE, EUN - YOUNG ET AL.: "Gram-Positive Bacteria Produce Membrane Vesicles: Pro- teomics-based Characterization of Staphylococcus Aureus-derived Membrane Vesicles", PROTEOMICS, vol. 9, no. 24, December 2009 (2009-12-01), pages 5425 - 5436 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3561069A4 (en) * 2016-12-26 2020-08-19 MD Healthcare Inc. METHOD OF DIAGNOSIS OF LUNG CANCER BY BACTERIAL METAGENOME ANALYSIS
EP3587596A4 (en) * 2017-02-24 2020-12-16 MD Healthcare Inc. METHOD OF DIAGNOSIS OF CHRONIC OBSTRUCTIVE RESPIRATORY DISEASE BY BACTERIAL METAGENOMANALYSIS
WO2019139360A1 (en) * 2018-01-12 2019-07-18 주식회사 엠디헬스케어 Nanovesicles derived from faecalibacterium prausnitzii, and uses thereof
WO2019139279A1 (en) * 2018-01-12 2019-07-18 주식회사 엠디헬스케어 Nanovesicles derived from morganella bacteria, and uses thereof
US10858670B2 (en) 2018-01-12 2020-12-08 Md Healthcare Inc. Nano-vesicles derived from genus Morganella bacteria and use thereof
US11666607B2 (en) 2018-01-12 2023-06-06 Md Healthcare Inc. Nanovesicles derived from Faecalibacterium prausnitzii and uses thereof
US11898156B2 (en) 2018-01-12 2024-02-13 Md Healthcare Inc. Nano-vesicles derived from genus Morganella bacteria and use thereof

Also Published As

Publication number Publication date
KR20160101521A (en) 2016-08-25

Similar Documents

Publication Publication Date Title
WO2016133324A1 (en) Method for diagnosing inflammatory respiratory diseases using outer membrane vesicles derived from bacteria
CN102573904B (en) Containing the composition and use thereof of extracellular vesicles coming from room air
JP6430648B2 (en) Identification method of causative bacteria of bacterial infectious diseases using bacteria-derived nanovesicles
Dzidic et al. Aberrant IgA responses to the gut microbiota during infancy precede asthma and allergy development
Shi et al. Dysbiosis of gut microbiota in patients with neuromyelitis optica spectrum disorders: a cross sectional study
Moentadj et al. Streptococcus species enriched in the oral cavity of patients with RA are a source of peptidoglycan-polysaccharide polymers that can induce arthritis in mice
CN104768560A (en) Diagnosis and treatment of autism spectrum disorder
Barbagallo et al. Microbiome differences in periodontal, peri-implant, and healthy sites: a cross-sectional pilot study
van den Munckhof et al. Nasal microbiota dominated by Moraxella spp. is associated with respiratory health in the elderly population: a case control study
EP1819827B1 (en) Methods for diagnosis of crohn&#39;s disease
Sanchez-Solares et al. Celiac disease causes epithelial disruption and regulatory T cell recruitment in the oral mucosa
Shi et al. Treatment of Guillain-Barré syndrome with Bifidobacterium infantis through regulation of T helper cells subsets
Cubells et al. Clinical data in children with meningococcal meningitis in a Spanish hospital
Li et al. Airway microbiota is associated with the severity of non‐CF bronchiectasis
Chen et al. Inflammation‐induced loss of CFTR‐expressing airway ionocytes in non‐eosinophilic asthma
El-Shabrawy et al. Role of fiberoptic bronchoscopy and BAL in assessment of the patients with non-responding pneumonia
Nahab et al. Study of Salmonella typhi isolated from patient suffering from typhoid fever in AL-Samawah city, Iraq
Milagres et al. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis
CN102590502A (en) Kit for auxiliary diagnosis of tuberculosis patients
Mozheiko et al. Specific features of the oral microbiome in young children with laryngopharyngeal reflux and its role the development of recurrent respiratory diseases
Zaman et al. Role of Respiratory Syncytial Virus and Some Bacteria Causes Tonsillitis among Children Under 5 Years Old in Duhok City.
Qi et al. The effect of oral bacterial lysates on the respiratory microbiome in patients with chronic obstructive pulmonary disease exacerbations–A pilot study
Shah et al. Study of extrapulmonary tuberculosis in tertiary care hospital children with reference to cartridge based nucleic acid amplification test
Brill et al. Haemophilus, antibiotic therapy and the airway microbiome in chronic obstructive pulmonarydisease
Djomo et al. Some Hepatic and Renal Biochemical Markers Associated with Salmonella Infections in Patients Consulting at the Bafoussam Regional Hospital and the Mifi District Hospital, West-Cameroon: Cross-sectional Study

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16752654

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16752654

Country of ref document: EP

Kind code of ref document: A1